Force containment in an automatic injector

Information

  • Patent Grant
  • 11364337
  • Patent Number
    11,364,337
  • Date Filed
    Monday, September 16, 2019
    5 years ago
  • Date Issued
    Tuesday, June 21, 2022
    2 years ago
Abstract
An automatic injector for delivering a pharmaceutical substance from a reservoir of a cartridge, the cartridge interconnected to a needle at its distal end and mechanically coupled to a plunger driver at its proximal end, the injector comprising a connecting feature on the cartridge a contact surface for contacting an injection site a frame connected to the contact surface, the frame having an interference element with a distal stop, the interference element sized to slidably link to the connecting feature and allow the cartridge to slide up to the distal stop, a snap element allowing the interference element to receive the connection feature, but inhibiting disconnection of the cartridge; the frame further comprising a driver mount, for fixedly containing a plunger driver, the driver for driving a plunger to empty the reservoir of the cartridge through the needle to inject fluid from the reservoir into the injection subject.
Description
FIELD AND BACKGROUND OF THE INVENTION

The present invention, in some embodiments thereof, relates to automatic injectors and, more particularly, but not exclusively, to force containment in automatic injectors.


U.S. Pat. Nos. 6,500,150, 6,824,529, and 6,843,782 disclose a drug delivery device having a base member defining a skin-contacting surface, a syringe serving as a reservoir for the drug, and means for expelling drug from the syringe. The syringe is connected to the base member such that the longitudinal axis of the syringe is substantially parallel to the skin surface. A delivery needle is in communication with the syringe. The needle has an angled bend which directs the tip of the needle substantially perpendicular to the skin-contacting surface. In use, the tip of the needle is adapted to penetrate the skin of the subject.


For such relatively slow release, an automatic expulsion device has also been suggested. U.S. Pat. No. 5,858,001 discloses a liquid drug delivery device adhered to the skin of a subject by a base member defining a skin-contacting surface having an adhesive coating. A columnar cartridge serves as reservoir for the drug and is incorporated in a housing which is connected to the base member such that in use the longitudinal axis of the cartridge is disposed substantially parallel to the skin-contacting surface. A delivery needle communicating in use with the interior of the cartridge penetrates the skin of the subject when the housing snaps downward relative to the base member. This action also causes the actuation of a citric acid/sodium bicarbonate gas generator which generates a gas to move a piston within the cartridge, compressing the drug compartment. This compression causes a stopper to be penetrated by a conduit in communication with the delivery needle, allowing the drug to be ejected from the compartment through the needle and into the subcutaneous tissue of the subject.


Additional background art includes U.S. Pat. No. 6,189,292. U.S. Patent Publication No. 20130253434, U.S. Patent Publication No. 2009/0093792, U.S. Pat. No. 7,967,795.


SUMMARY OF THE INVENTION
Example 1

An automatic injector for delivering a pharmaceutical substance from a reservoir of a cartridge, the cartridge interconnected to a needle at its distal end and mechanically coupled to a plunger driver at its proximal end, the injector comprising a connecting feature on the cartridge; a contact surface for contacting an injection site a frame connected to the contact surface, the frame having: an interference element with a distal stop, the interference element sized to slidably link to the connecting feature and allow the cartridge to slide up to the distal stop, a snap element allowing the interference element to receive the connection feature, but inhibiting disconnection of the cartridge; the frame further comprising a driver mount, for fixedly containing a plunger driver, the driver for driving a plunger to empty the reservoir of the cartridge through the needle to inject fluid from the reservoir into the injection subject.


Example 2

The automatic injector of example 1, wherein the frame is unitary.


Example 3

The automatic injector of example 1, wherein the frame comprises a motor mount, for fixedly containing a motor in operable communication with the plunger driver.


Example 4

The automatic injector of example 3, wherein the motor, the driver and the reservoir having longitudinal axes positioned on the same plane.


Example 5

The automatic injector of example 1, wherein the frame is positioned in a proximal portion of the housing.


Example 6

The automatic injector of example 1, wherein the frame is suitable for reducing translational movement of the cartridge.


Example 7

The automatic injector of example 1, wherein the frame is suitable for reducing rotational movement of the cartridge.


Example 8

The automatic injector of example 1, wherein the driver mount comprises a walled container having a top opening.


Example 9

The automatic injector of example 8, further comprising a top cover having at least one extension complementing at least one gap in the walled container.


Example 10

The automatic injector of example 9, wherein the top cover comprises an extension sized to fit between a gap in a proximal wall of the walled container and a proximal portion of the plunger driver, once the plunger driver slides in a distal direction.


Example 11

A receiving frame for immobilizing a cartridge having a connection feature to an automatic injector housing, the cartridge having a needle at its distal end, and is mechanically coupled in its proximal end to a plunger driver, comprising a ventral side for fitting into a base portion of the automatic injector; and a dorsal side having: a cartridge mount for receiving the cartridge from above, the cartridge mount comprises a interference element with a distal stop, the interference element sized to slidably link to the connection feature and allow the cartridge to slide up to the distal stop, and a snap element allowing the interference element to receive the connection feature, but inhibiting disconnection of the cartridge; and a driver mount, for fixedly containing the plunger driver, the driver mount comprising a walled container sized to at least partially surround the plunger driver and having an open top for receiving the plunger driver from above; wherein the cartridge and the driver are mechanically coupled through the plunger.


Example 12

The receiving frame of example 11, further comprising a motor mount, for fixedly containing a motor in operable communication with the plunger driver, the motor mount comprising a walled container sized to at least partially surround the motor and having an open top for receiving the motor from above;


Example 13

The receiving frame of example 11, wherein the cartridge mount, the driver mount and the motor mount are made of a unitary piece.


Example 14

The receiving frame of example 11, wherein longitudinal axes of the cartridge, the plunger driver and the motor are positioned on the same plane.


Example 15

The receiving frame of example 11, wherein the driver mount contains forces of at least 20 Kg*cm.


Example 16

The receiving frame of example 11, wherein the interference fit is shaped to surround a portion of the cartridge from a dorsal, a distal and a ventral side of the cartridge portion.


Example 17

A method of connecting a cartridge having a connection feature to an automatic injector having a motor, the cartridge interconnected to a needle at its distal end and mechanically coupled to a plunger driver at its proximal end, comprising lowering the cartridge while being mechanically coupled with the plunger driver into a receiving frame of the automatic injector, the receiving frame having an open top; sliding the cartridge in a direction of the distal end until reaching a distal stop; linking the connection feature to an interference element of the receiving frame; snapping the connection feature, such that disconnection of the cartridge is inhibited; and containing forces generated by the plunger driver on the cartridge through the receiving frame, thereby immobilizing the cartridge with respect to the automatic injector.


Example 18

The method of example 17, wherein the containing forces comprises mechanically interfering with an axial translation of the cartridge.


Example 19

The method of example 17, wherein the containing forces comprises mechanically interfering with a rotational translation of the cartridge.


Example 20

The method of example 17, wherein the interlocking comprises surrounding a portion of the cartridge from at least four directions being a dorsal side, a ventral side, a proximal side and a distal side.


Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.


In the drawings:



FIG. 1 is a block diagram schematically representing an automatic injector receiving frame for fitting with a cartridge and a driving system of the cartridge, in accordance with some embodiments of the invention;



FIG. 2 is a high level overview of a method for immobilizing movement of a cartridge with respect to an automatic injector assembly, in accordance with some embodiments of the invention;



FIG. 3A is an exemplary unitary receiving frame illustrating a distal and proximal geometry for fitting with and immobilizing components of an automatic injector, in accordance with some embodiments of the invention;



FIG. 3B is an exemplary unitary receiving frame fitted with various components of an automatic injector, in accordance with some embodiments of the invention;



FIG. 4 is an exemplary cartridge having distal and proximal mounting pins for connecting with a receiving frame, in accordance with some embodiments of the invention;



FIG. 5 is an explosive view of an automatic injector being loaded with a cartridge and covered with a cover, in accordance with some embodiments of the invention;



FIG. 6 is a close-up cross-sectional view of an exemplary geometry and interference connection of a proximal portion of a unitary receiving frame with a proximal portion of a cartridge, in accordance with some embodiments of the invention;



FIG. 7 is a perspective top view of an exemplary side-by-side configuration of the cartridge and the driving system of the cartridge, in accordance with some embodiments of the invention;



FIGS. 8A and 8B illustrate a side view of a snap fitting and immobilization of a cartridge, in accordance with some embodiments of the invention, wherein FIG. 8A illustrates a cross-sectional view of FIG. 8B illustrates a partial perspective view;



FIG. 9 is a cross-sectional side view of the automatic injector, illustrating an incorporation of a cover extension in the immobilization system, in accordance with some embodiments of the invention; and



FIG. 10 illustrates a bottom perspective view of an exemplary unitary receiving frame, showing a distal fitting with a cartridge, in accordance with some embodiments of the invention.





DESCRIPTION OF SPECIFIC EMBODIMENTS OF THE INVENTION

The present invention, in some embodiments thereof, relates to automatic injectors and, more particularly, but not exclusively, to force containment in automatic injectors.


Overview

An aspect of several embodiments of the invention relates to immobilizing a cartridge with respect to an automatic injector mounting plate, the mounting plate used for mounting over an injection subject. In some embodiments, immobilizing includes reducing axial translation of the cartridge, for example, axial translation of the cartridge towards the distal end of the mounting plate, defined as the end comprising an injection needle, and/or axial translation of the cartridge towards the proximal end of the mounting plate, defined as the end comprising a plunger. Alternatively or additionally, immobilizing comprises inhibiting rotational movement of the cartridge, for example, movement in the form of rotation around the longitudinal axis of the cartridge.


In some embodiments, it is desirable that the cartridge is immobilized in the injector sufficiently that operating the plunger mechanism to expel the contents does not move the cartridge. If the cartridge were to move then the needle may cause discomfort to the patient in the skin around the needle. This is especially relevant for a cartridge having a bent fluid path, which translates any rotational movement of the cartridge into an axial translation movement of the elongated axis of the needle.


In order to provide such immobilization, in some embodiments, a receiving frame is provided within the injector mounting plate to receive the cartridge. Optionally, the cartridge is fixedly received, i.e. while the cartridge is received it is also fixed to the receiving frame. For example, fixed includes immobilizing movement of more than 0.1 mm, and/or more than 0.5 mm, and/or more than 1 mm, and/or more than 2 mm, and/or more than 4 mm. In some embodiments, the receiving frame engages the cartridge such that forces exerted on the cartridge, forces which might cause its translation and/or rotation, are sufficiently reduced. Alternatively or additionally, the receiving frame is provided to contain force generated by components which are mechanically coupled to the cartridge. In some embodiments, the cartridge is mechanically coupled to a plunger driver, optionally by having a driving system which is mechanically connected to a plunger residing within the reservoir of the cartridge. In some embodiments, the plunger driver is found in a mechanical operable communication with a motor, optionally through a transmission system. Optionally, forces generated by the motor, and/or by the plunger driver are contained within the receiving frame. In some embodiments, a single frame is used for fixedly receiving the cartridge and its associated plunger driver and/or motor.


Optionally, the receiving frame is formed as a unitary frame. As used herein, unitary includes being formed and/or molded as a single unit, without having more than one component. It should be noted that having a plurality of components being interlocked to form a single unit, are not included herein in the scope of the term unitary. In order to avoid movement of the distal portion of the cartridge, where the needle is positioned, it is preferable to dissipate forces near their source, e.g. the proximal portion comprising the motor and driving system. Alternatively or additionally, it is useful to utilize a receiving frame having as little as possible different parts, such as no more than three, or no more than two, or no more than one unitary frame.


In some embodiments, the receiving frame comprises a dorsal side for fixedly receiving at least the cartridge, and a ventral side for placing onto a mounting plate. Optionally, the receiving frame is hingely connected to the mounting plate, optionally at its sides. In some embodiments, it is desirable that the injector housing would have a small height, potentially enabling easier gripping. In some embodiments, the height may be reduced by positioning of the cartridge, the driver mount and the motor in a side-by-side arrangement, for example by positioning the longitudinal axes of each of the cartridge, the plunger driver and the motor on the same plane, optionally, parallel to the plane defined by the base of the housing, and/or the plane used for mounting on the injection subject.


In some embodiments, the receiving frame comprises at least one interference element which has a geometry for holding the cartridge. In some embodiments, the interference element engages with a connection feature, such as for example a complementary geometry, comprised in the cartridge. For example, the interference element may include holders into which complementary geometry in the form of extensions on the body of the cartridge can slide into. In some embodiments, the cartridge and its complementary geometry slide towards the distal end of the housing, up to a distal stop. Optionally, the complementary geometry is then latched at a final resting position by a catch located behind, so that the cartridge can be inserted with a down, slide and click operation. As used herein, an interference element includes a restraining geometry for engaging with a connection feature of the cartridge, for example, by enveloping the connection feature from three directions, or being enveloped by the connection feature in three directions.


Alternatively or additionally, the cartridge may include a complementary geometry in the form of flange and/or cut out and/or bevel and/or an indentation and/or a protrusion and/or a pin and/or a stabilizer and/or a hole and/or a snap fitting and/or hook and/or a pin designed to mate with the fitting of the interference element of the receiving frame. Optionally, the interference element includes a flange and/or cut out and/or bevel and/or an indentation and/or a protrusion and/or a pin and/or a stabilizer and/or a hole and/or a snap fitting and/or hook and/or a pin.


In some embodiments, a non-symmetric cartridge is provided. Optionally, loading the non-symmetric syringe into a device in the correct orientation requires reference points and/or connection features. In some embodiments, the fitted geometry of the interference elements with the complementary geometry of the cartridge serves as reference points.


In some embodiments, interference elements are sized and shaped to accommodate three sides of the complementary geometry, optionally the dorsal side, the ventral side and the distal side, resulting in a holder which holds the complementary geometry in three directions. Alternatively, it is the complementary geometry which surrounds the interference element, optionally across the dorsal side, the ventral side and the proximal side. In some embodiments, mechanically interfering across the dorsal and ventral portions of the complementary elements mechanically hinders their movement. In some embodiments, at least two interference elements are provided in opposite locations positions along the longitudinal axis of the cartridge, each positioned at an opposite location across the cartridge reservoir. Potentially, providing mechanical interference in at least two locations positioned across the circular diameter of the cartridge reduces rotational movement.


In some embodiments, after the cartridge slides to be engaged with the interference elements, up to the distal stop, an elastic element closes a fourth side of the cartridge. For example, a snap may be elastically pushed down when lowering the cartridge into the receiving frame, and once the cartridge slides towards the distal end, the elastic element is released and secures the cartridge from a fourth side, such as the proximal side. Optionally, the elastic element is a snap. In some embodiments, at least two snaps are provided, each securing an engagement of at least two interference elements with complementary geometries. In some embodiments, securing the complementary geometry of the cartridge from the distal end, such as by the distal stop, and from the proximal end, such as by the elastic element, reduces movement in a lateral, axial translocation.


In some embodiments, the receiving frame is configured to hold the proximal side of the cartridge and the plunger driver together. In some embodiments, the walled driver mount balances rearward forces of the plunger driver while the interference elements balance longitudinal forces between the plunger driver and the cartridge. In some embodiments, torque formed between the transmission, the plunger driver and the cartridge is directed to the proximal portion of the receiving frame. In some embodiments, the interference elements and the walled containments prevent movement in a distal direction, in an upwards direction or in a rotation around the axis of the cartridge. In some embodiments, the proximal elastic element prevents the cartridge from moving proximally and also prevents the cartridge from being disconnected from the receiving frame.


In some embodiments, the receiving frame comprises a distal complementary element for engaging and stabilizing a distal portion of the cartridge near the needle. In some embodiments, the cartridge comprises a bent fluid path extending from a dorsal outlet and bending towards the ventral side of the cartridge. In some embodiments, the distal complementary element is positioned on the free ventral side of the cartridge. In some embodiments, when the distal complementary element is engaged with the receiving frame, forces emanating from the needle, such as from usage of the needle or from delivery shocks, are dissipated. For example, a distal portion of a cartridge might have has an elongated protrusion, extending beyond the edge of the cartridge, and being complementary to slide into a hole provided in the receiving frame. In some embodiments, distal connectors hold the needle steady against vertical forces of needle insertion or lateral forces against the needle. In some embodiments, the fitting geometry also prevents forward movement in the axial direction. In some embodiments, the distal pin is within the cross section of the cartridge and does not interfere with a process for filling the cartridge.


In some embodiments, the cartridge itself comprises complementary geometry elements for fitting with geometric elements in the receiving frame. In some embodiments, a cross-section across a reservoir of the cartridge lacks an axial symmetry, for example, it is not round. Alternatively or additionally, the cross-section across a reservoir of the cartridge has a central symmetry, for example, by having a geometrical element on either side of the reservoir. In some embodiments, the cartridge is manufactured by molding, optionally Crystal Zenith. A potential advantage of molding is the possibility to build into the cartridge geometric features which make the syringe easier to mount in an injection device. Alternatively or additionally, the syringe may include a molded component. Optionally the molded component includes the extension. For example the molded component may be made of Daikyo Resin CZ (Crystal Zenith) or other Cyclic Olefin Polymer (COP) or any moldable material suitable to use with drug product. Alternatively or additionally, molded components may be made of, for example, polycarbonate and/or polypropylene and/or other polymers.


An aspect of some embodiments of the invention relates to a receiving frame to be fit within of an automatic injector, optionally within a proximal portion, and for containing forces generated between a motor, a plunger driver and a cartridge comprising the plunger. In some embodiments, a unitary frame is provided having at least two mount containments, one for each of the plunger driver and the cartridge. In some embodiments, the unitary frame is further provided with a third mount containment for the motor. Optionally, the unitary frame comprises walls for containing and dissipating the forces emanating from each of the motor and/or the plunger driver.


In some embodiments, the receiving frame is configured to receive from above a cartridge being mechanically coupled to the plunger driver. Optionally, the cartridge is mechanically coupled to the plunger driver through a plunger which resides within the reservoir of the cartridge and is mechanically connected to at least one arm of the plunger driver. In some embodiments, the plunger driver comprises a driving assembly, optionally a telescopic system. For example, the plunger driver may include threaded telescoping rods such that when a transmission is rotated (for example by a motor) the telescoping rods expand the plunger into the reservoir possibly causing discharge of a pharmaceutical substance out of the cartridge fluid path.


Alternatively, the receiving frame is configured to receive from above a cartridge being mechanically coupled to the plunger driver and to the motor, for example, through a transmission mechanically coupling an operative communication between the motor and the plunger driver.


In some embodiments, the mount containments of the receiving frame comprise an open top, allowing the lowering of the cartridge and its associated components into the receiving frame from above. In some embodiments, the geometry of the receiving frame is configured to allow lateral sliding of the cartridge with the plunger driver, for example towards the distal end of the receiving frame.


For automatic operation, in some embodiments, an electric motor is provided to operate the plunger. In order to lower the profile of the device so that it is easy to hold flat and still against the skin, the motor is in some embodiments placed along an axis that is on the same plane as an axis of the cartridge. Optionally, the motor and the cartridge/plunger axes are parallel to each other. Further optionally, both are substantially perpendicular to the axis of injection into the skin, for example, when the cartridge comprises a bent fluid path.


In some embodiments, a cartridge mount is provided in the receiving frame for receiving the cartridge from above. Optionally the cartridge is fixed to the receiving frame after it is lowered into the receiving frame. Alternatively, the cartridge is fixed to the receiving frame while it is being lowered into the receiving frame. As used herein, fixed to the receiving frame relates to restraining the cartridge in place, for example inhibiting its movement for more than 0.1 mm, and/or more than 0.5 mm, and/or more than 1 mm, and/or more than 2 mm, and/or more than 4 mm. In some embodiments, the cartridge mount comprises the interference element with the distal stop, the interference element sized to slidably receive the cartridge and allow the cartridge to slide up to the distal stop.


In some embodiments, a driver mount is provided in the receiving frame for fixedly containing the driver mount. In some embodiments, the driver mount comprises a walled compartment, at least partially surrounding the plunger driver. In some embodiments, the close proximity of the walls of the compartment to the plunger driver causes forces generated in the plunger driver to dissipate, such that forces that might reach the cartridge are reduced.


In some embodiments, the walled containment of the driver mount comprises a gap in its proximal end, sized to accommodate a proximal portion of the driver plunger. Optionally, the gap assists in eliminating mechanical interference when lowering the cartridge with the driver plunger into the receiving frame. In some embodiments, once the cartridge and its associated driver plunger are shifted towards the distal side of the housing, the gap no longer accommodates the driver plunger. Optionally, a housing top cover comprises an extension sized and/or shaped to fit between the gap and the proximal portion of the plunger driver. Optionally, the cover extension serves as an additional supporting wall, aiding in the force dissipation of the driver mount.


In some embodiments, a motor mount is provided in the receiving frame to contain the motor and dissipate forces generated by the motor. In some embodiments, the motor mount comprises an open top for receiving the motor from above. Optionally, the motor mount comprises at least two walls, optionally oppositely positioned, sized to fit over the motor sides, optionally its longitudinal sides. In some embodiments, the walls comprise a rail for slidably guiding and securing the receiving of the motor.


Optionally, the receiving frame is provided with a transmission mount. In some embodiments, the transmission mount is positioned between the motor mount and the plunger driver mount. In some embodiments, the transmission mount comprises an elongated rod configured for fitting with a center of a wheeled transmission system.


In some embodiments, the driver mount and/or the motor mount are suitable for containing forces of at least 10 Kg-cm, or at least 15 Kg-cm, or at least 20 Kg-cm, or at least 25 Kg-cm.


An aspect of some embodiments of the invention relates to force containment between a cartridge having a bent fluid path and an automatic injector apparatus. In some embodiments, force containment comprises reducing movement of a needle of the cartridge with respect to the injector base, which might arise from force exerted on the cartridge, for example, when driving fluid out of the cartridge. In some embodiments, an injector base is provided with a unitary mounting frame having interfering geometry for fitting with the cartridge, optionally at least for fitting with a distal portion of the cartridge and a proximal portion of the cartridge.


In some embodiments, the unitary frame is configured to contain forces along a longitudinal axis of the cartridge. Specifically, in some embodiments, the high forces between the plunger driver system and the plunger are dissipated. Typically, relatively high forces may be exerted on the cartridge by the plunger driving system, for example, about 3-4 Kg. High forces may cause instability of the cartridge which may lead to movement and/or breakage of the cartridge.


Alternatively or additionally, the unitary frame is configured to contain rotational forces. In some embodiments, the cartridge is connected to the needle at an angle, resulting in a configuration which is sensitive to both lateral and rotational movements of the cartridge, where small movements (rotation and/or translation) of the syringe may cause pain to the user or failure of the device. This is as opposed to syringes having a straight needle, which typically are not sensitive to a rotational displacement.


In some embodiments, the unitary frame structure is designed to create a local force balance at cartridge locations prone to impact, for example, at the distal end of the cartridge comprising the needle, where force is exerted when the needle is being pushed into a user's body, and/or at the proximal end comprising the plunger driving assembly, where forces are exerted on the plunger in order to drive fluid out of the cartridge. A potential advantage of using a unitary frame for containing longitudinal force along an axis is the durability of the frame to withstand the forces exerted by the injector operation, potentially reducing breakage and/or disassembly, which might arise in a plurality of interconnected components. Often longitudinal forces are balanced on different parts and/or at different ends of the syringe. For example, proximal plunger driving forces may be absorbed by a door at the proximal end, while a distal force against the cartridge may be absorbed by the injector housing at the front of the injector. This may cause instability of the injector and/or cause high forces on joints between parts.


An aspect of some embodiments of the invention relates to a low profile patch auto injector. In some embodiments a low profile patch auto injector may include a frame fitted to accommodate a cartridge. In some embodiments, the frame is walled. In some embodiments, the frame is pivotly connected at the front, distal end (needle end) of the injector to a base. In some embodiments the injector includes a cover. In some embodiments, the syringe in the cartridge is symmetric. In some embodiments, the syringe in the cartridge is non-symmetric. In some embodiments the frame includes a receiving frame that supports the cartridge.


In some embodiments, at least a portion of the walled frame is floored. In some embodiments, the height of the frame wall varies at different locations. In some embodiments, the wall is continuous throughout its circumference. In some embodiments, the wall is discontinuous in portions of its circumference. In some embodiments, the cover fits over the frame wall. In some embodiments, the cover walls follow and parallel the frame wall. In some embodiments, the cover wall covers missing portions of the frame wall. In some embodiments, the cover includes a removable central section. In some embodiments, the cover central section includes a wall that parallels a portion of the cover wall forming a double wall at that location.


An aspect of some embodiments of the invention relates to a receiving frame that supports the cartridge. In some embodiments, the receiving frame includes a stress containment enclosure. In some embodiments, the stress containment enclosure mechanically mediates stress effected on the frame by the syringe and vice versa. In some embodiments the enclosure includes a portion of the injector cover. In some embodiments, the stress containment enclosure steadies and stabilizes the cartridge. In some embodiments, the receiving frame includes means for supporting the cartridge. In some embodiments, the receiving frame includes coupling mechanisms to attach the cartridge thereto. In some embodiments, the coupling mechanism includes the injector cover. In some embodiments the cartridge includes gripping members. In some embodiments, the receiving frame-cartridge coupling mechanisms function as guides and guide a cartridge being mounted to its correct final location on the receiving frame. In some embodiments the receiving frame supports the injector syringe plunger driving power train.


In some embodiments, the receiving frame supports a printed circuit board (PCB). In some embodiments, the receiving frame supports cover locking/unlocking mechanism. In some embodiments, the receiving frame provides structural support to the frame.


The cartridge may be pre-filled in a sterile aseptic environment using standard equipment for filling syringes prior to insertion in the injector. The injector itself need not be sterile. As the needle is molded into the cartridge it is desirable that the cartridge is immobilized in the injector sufficiently that operating the plunger mechanism to expel the contents does not move the cartridge. If the cartridge were to move then the needle may cause discomfort to the patient in the skin around the needle. In order to provide such immobilization, there may be provided a clip that fits within the injector and which has a catch mechanism for holding the cartridge. The catch mechanism may include bridge holders into which extensions on the body of the cartridge can slide and then be latched at a final resting position by a catch located behind, so that the cartridge can be inserted with a down, slide and click operation.


The injector may provide for insertion of the needle by a simple action of pressing by the user, whether patient or medical personnel when the injector is located on the skin. The needle cover is removed, the injector is placed on the skin and a button is pressed.


Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.


Cartridge Immobilization Block Diagram


Referring now to the drawings, FIG. 1 shows a block diagram representing an automatic injector mounting frame for fitting with a cartridge and a driving system of the cartridge, in accordance with some embodiments of the invention.


In some embodiments, an automatic patch injector is mounted on an injection subject. In some embodiments, the automatic injector comprises mounting plate 101. In some embodiments, mounting plate 101 is used for holding the device and for containing the internal components of the injector, such as cartridge 120 having needle 116 at its distal end 104 and plunger 141 at its proximal end 106. In some embodiments, cartridge 120 comprises a reservoir, optionally filled with a pharmaceutical substance. As used herein, a pharmaceutical substance comprises any fluid used for injecting into an injection subject, such as a drug, a placebo, a nutrient and so forth.


In some embodiments, mounting plate 101 comprises receiving frame 110 for fixedly containing at least some of the internal components of the automatic injector. Optionally, receiving frame 110 is unitary, i.e. made from a single piece of material. In some embodiments, receiving frame 110 comprises a ventral side for fixing with mounting plate 101 and/or the injector's base portion, and a dorsal side having geometry for containing internal injector components.


In some embodiments, forces are generated by motor 170 and transmitted to plunger driver 140, optionally through a transmission system. In some embodiments, large forces, for example 3-5 Kg, are generated by plunger driver 140 when driving plunger 141 inside cartridge 120. In order to eliminate forces over the longitudinal axis of the cartridge, which might give in and break, in some embodiments forces are dissipated by receiving frame 110 in proximity to their generation site.


In some embodiments, receiving frame 110 comprises geometries for fixedly containing force generating components and/or force affected components. For example, receiving frame 110 may comprise the driving system of the injector which includes at least a cartridge mount for fixedly receiving cartridge 120, a driver mount for containing plunger driver 140 and a motor mount for containing motor 170. In some embodiments, forces are locally balanced. In some embodiments, receiving frame 110 comprises geometry which contains the components of the driving system of the injector in proximity to one another, for example in proximal end 106. A potential advantage of containing force exerting and exerted components in proximity is that forces may be dissipated close to where they are generated and/or affecting, without being projected to other regions of the injector. Another potential advantage of a limited space for containing force is that force containing structures in receiving frame 110 are provided at the limited region, reducing redundancy of structures.


In some embodiments, receiving frame 110 comprises a platform, e.g. a planer structure. In some embodiments, the components of the driving system, at least cartridge 120, plunger driver 140 and motor 170, are contained side-by-side over the platform, optionally each of the components are placed along their longitudinal axis. In some embodiments, the longitudinal axes of cartridge 120, plunger driver 140 and motor 170 are positioned on the same plane, and/or parallel planes, optionally additionally parallel to the injector base plane. A potential advantage of placing the longitudinal axes laterally on substantially the same plane is limiting the height of the housing and injector device, possibly making it easier to be held by hand, and easier to transport.


High Level Overview of Cartridge Immobilization


Reference is now made to FIG. 2, showing a high level overview of a method for immobilizing movement of a cartridge with respect to an automatic injector housing, in accordance with some embodiments of the invention.


In some embodiments, a housing is provided 202 having within it a receiving frame. In some embodiments, the receiving frame serves as a chassis, containing the internal components of the injector. In some embodiments, a cartridge is lowered 204 into the receiving frame fitted within the housing from above. Optionally, the cartridge is lowered while being mechanically coupled to a plunger driver. In some embodiments, mechanical coupling between the cartridge and the plunger driver comprises an arm, optionally telescopically extended, which mechanically connects to a plunger residing within the reservoir of the cartridge. Alternatively or additionally, the cartridge may be lowered into the receiving frame while being mechanically coupled to a motor, the motor being in operable mechanical communication with the plunger driver, optionally through a transmission system.


In some embodiments, the cartridge, and possibly its associated components, is being laterally moved by sliding 206 towards the distal end of the receiving frame, defined as the end fitting with the distal portion of the cartridge, which comprises the needle outlet. In some embodiments, by sliding the cartridge in 206, the cartridge is interlocked 208 with the receiving frame, optionally by engaging with geometry provided in the receiving frame, such as interference elements and/or snap latches. A potential advantage of activating engagement by positional translocation into a fitting geometry is that it enables a delicate interlocking mechanism, i.e. a mechanism which requires a small amount of force to apply, as opposed to a mechanism of elastic fitting which operates on the basis of first pushing away the interfering element, instead of sliding into it.


In some embodiments, the cartridge is lowered down from above while being mechanically coupled with the driving system of the injector, e.g. the plunger driver and/or the motor. In some embodiments, the receiving frame contains walled compartments for receiving the coupled components of the cartridge. In some embodiments, the walled compartments are not uniform in wall height, for example having gaps, and enable some portions of the driving system to extend beyond the boundaries of the walled compartments. Optionally, by sliding 206 the cartridge into its interlocked position, the driving system components extending beyond the boundaries are shifted to be positioned as a whole inside the boundaries of the walled compartments. In some embodiments, a space is formed between the wall having the gap and the driving system components.


Optionally, the receiving frame is covered 210 with a housing cover. In some embodiments, the housing cover complements gapped regions in the walled compartments of the receiving frame. In some embodiments, the housing cover comprises extensions sized and/or shaped for fitting in the space between the wall and the shifted component. In some embodiments, the filling in of the extension provides mechanical support for the components, aiding in the dissipation of the force emanating from the components. For example, being mechanically connected to the plunger, the plunger driver may be found in a proximal position to the cartridge. A gap in the walled compartment containing the plunger driver enables the proximal portion of the plunger driver to extend beyond the boundary of the wall. When the cartridge is shifted distally by sliding, so does the coupled plunger driver. By shifting distally, the plunger driver may now be fully contained within the compartment.


However, the remaining gap may lead to insufficient containment of forces which cause the plunger driver to shift towards a proximal direction. Filling this space with the cover, may provide a supporting wall that would balance these forces, reducing movement of the plunger driver. In some embodiments, the plunger driver delivers 212 fluid by extending a threaded telescopic extension towards the distal direction, where the plunger is with respect to the plunger driver. The plunger is then pushed towards the distally located outlet comprising the needle, driving the fluid out of the cartridge. Providing the proximal support in the form of the walled compartment, provides an anchoring point enables the extending arm to push the plunger distally, against the pressure of the fluid, rather than having the plunger driver being pushed proximally.


Exemplary Unitary Mounting Frame


Reference is now made to FIG. 3A, illustrating an exemplary unitary mounting frame illustrating a distal and proximal geometry for fitting with and immobilizing components of an injector, in accordance with some embodiments of the invention.


In some embodiments, receiving frame 110 comprises two regions of geometric fitting, a proximal region and a distal region. In some embodiments, a distal region secures the distal portion of cartridge 120 by distal mount 325, exemplified and illustrated, for example in FIG. 4, showing the distal mounting pin 422 of cartridge 120 and FIG. 10 showing the distal mount engaged with the distal mounting pin 422 of cartridge 120. In some embodiments, a proximal region of receiving frame 110 comprises the proximal force generating components of the injector. In some embodiments, the two regions are positioned on floor 111 of receiving frame, which is optionally not continuous between the regions, as exemplified and shown in FIG. 10. In some embodiments, floor 111 is substantially flat and serves as a base on which the complementary geometries of receiving frame 110.


In some embodiments, a proximal portion of receiving frame comprises a cartridge mount 327, a plunger driver mount 315 and a motor mount 317. Optionally, all mounts are found in proximity to one another, potentially dissipating forces near their generation sites and reducing forces propagation into less secured components and regions. In some embodiments, each mount contains geometric features which are sized and shaped to contain the injector components. Optionally, the receiving frame and its geometric features are unitary, for example, by generating them in a molding process. In some embodiments, the mounts comprise joint walls and/or geometries for containing forces from both sides of the mounts.


In some embodiments, cartridge mount 327 comprises complementary geometry for fitting with geometric structures in the proximal end of cartridge 120. For example, interference elements 332, distal stop 333 and snaps 334, which are further exemplified and illustrated in FIGS. 6, 8A, 8B, 9 and 10.


In some embodiments, driver mount 315 comprises walls 316 defining a containing compartment, optionally covering at least a portion of three sides of the plunger driver. In some embodiments, a forth side of the plunger driver is secured by being mechanically coupled to cartridge 120. Potentially, the walls stabilize the forces generated by plunger driver 140 and prevent its movement in at least three directions. It is a potential advantage to immobilize the plunger driver when it is mechanically coupled to the cartridge, in order to reduce movement which would result in movement of the cartridge. In addition, dissipating forces close to their generating sites reduces the effect of these forces at other sites.


In some embodiments, driver mount 317 is open topped, allowing for the plunger driver to be loaded from above. In some embodiments, due to its coupling to cartridge 120, and since cartridge 120 is distally shifted, the geometry of driver mount 317 permits a distal translocation of plunger driver 140, for example, by providing a walled compartment which is bigger than the distal-proximal axis of plunger driver 140. In some embodiments, a space formed between the proximal wall and the proximal end of driver 140 is filled by an extension of the housing cover, optionally sized and/or shaped for fitting into the formed to space. In some embodiments, gap 320 is provided to allow for a more proximal positioning of driver 140, without mechanical interference by the proximal wall. Gap 320 is further shown and illustrated in FIG. 3B and FIG. 9.


In some embodiments, a motor mount 317 is provided, optionally in proximity to the proximal end of the cartridge which is relatively secured. In some embodiments, motor mount is positioned laterally with respect to driver mount 315. In some embodiments, motor mount comprises walls 318 fitting the width of motor 170. Optionally, walls 318 comprise guiding rails 319, guiding an insertion of motor 170 into its mount 317. In some embodiments, walls 318 are not continuous and provide access for a transmission system to interconnect between the motor 170 and plunger driver 140.


Exemplary Unitary Mounting Frame Fitted with Various Components of an Automatic Injector


Reference is now made to FIG. 3B, an exemplary unitary mounting frame fitted with some components of an automatic injector, in accordance with some embodiments of the invention.


In some embodiments, an automatic injector device includes an actuator, for example motor 170, optionally DC motor. In some embodiments, an automatic injector device includes transmission 302, for example mechanically coupled to a plunger driver 140. In some embodiments, an automatic injector device includes a power source. When the power source is electrically connected to motor 170, motor 170 optionally rotates gear wheels of transmission 302 being attached to driving plunger 141 to discharge a drug.


Optionally a cartridge 120 may be installed into the device (for example preinstalled and/or installed by a user). In some embodiments the cartridge may include reservoir 410 optionally containing a drug and/or plugged at a proximal location with a plunger seal 140 and/or having an extension 305 and/or needle 116, optionally protected by a needle cap (not shown). Optionally plunger driver 140 may also be a part of cartridge 120. Alternatively or additionally plunger driver 140 may be part of the injector device.


In some embodiments, receiving frame 110 further comprises an electric motor 170 for operating plunger 141 to empty the reservoir 410 into needle 116, optionally to inject fluid from the reservoir 410 into the injection subject. In some embodiments, the motor and the reservoir have parallel longitudinal axes, optionally typically perpendicular to the axis of the needle at the point of injection. In some embodiments, motor 170 is held to receiving frame 110 by mountings 318 and operates transmission 302, optionally having a succession of gear wheels, to advance plunger 141.


Exemplary Cartridge


Reference is now made to FIG. 4, illustrating an exemplary cartridge having distal and proximal mounting pins for connecting with a mounting frame, in accordance with some embodiments of the invention.


In some embodiments, the automatic injector cartridge comprises complementary geometry for fitting with the geometry provided in receiving frame 110. For example, the proximal end of cartridge 120 comprises mounting pins 425, which may engage with cavities 332 in receiving frame 110. In some embodiments, mounting pins 425 extend beyond the outer boundary of the body of reservoir 410. Optionally, mounting pins 425 are connected through pin connection 427, which may be for example an extended rod connecting between the pins and potentially providing greater stability and strength than pins which are unrelated to one another. In some embodiments, mounting pins 425, and optionally connection 427, together with their complementary geometry in the receiving frame, determine the directionality of insertion of cartridge 120 into the injector. It is a potential advantage to provide directionality indicators such as pins 425, when using an off-centered fluid outlet, and/or when using a bent fluid path, both defining a preferable orientation with respect to an injection subject.


In some embodiments, a distal complementary geometry is provided at the distal end of cartridge 120. For example, distal mounting pin 422 is provided as an extension protruding from the distal boundary of the cartridge, optionally centered. In some embodiments, pin 422 is sized to fit with fitting geometry on the proximal end of receiving frame 110.


In some embodiments, both pins 425 and pin 422 are shaped to engage with cavities which are positioned distally to the pins. This directionality enables the loading of the cartridge by sliding it towards the distal cavities until reaching a mechanical stop. For example, until pins 425 run into distal stop 333, and/or until pin 422 is fully inserted into cavity 325 and the cartridge distal wall mechanically inhibits further movement. Optionally, mounting pins 425 are proximally secured by snaps which elastically deflect to allow lowering the cartridge, and snap back into position when the mounting pins 425 are slid distally.


Exemplary Cartridge Loading into an Injector and Fitting with a Unitary Mounting Frame


Reference is now made to FIG. 5, illustrating an explosive view of an automatic injector being loaded with a cartridge and covered with a cover, in accordance with some embodiments of the invention.


In some embodiments, the injector has a base part 520 which is placed in contact with the skin of a subject to receive the injection. In some embodiments, receiving frame 110 receives and fixes cartridge 120 within mounting plate 101. The mounting plate 101 is pivotally mounted on base 520.


In some embodiments, receiving frame 110 comprises an interference element 332 with a distal stop 333 and optionally snap, for example elastic snap lock 334. The cartridge is lowered vertically into the slide connecter, pushing down snap 334. The cartridge is then slid forward to the distal stop and upon reaching the distal stop the latch is released to latch the cartridge in place from behind against the distal stop. The down, slide, click motion of inserting the cartridge into receiving frame 110 is illustrated by arrows A and B, illustrating the downwards loading and the lateral sliding towards the distal end, respectively.


In some embodiments, cover 510 fits on mounting plate 101 over the reservoir part of the cartridge 120, after the cartridge is placed in position, optionally having extensions, for example extension 512, for filling in the space which is formed between plunger driver 140 and receiving frame 110.


Exemplary Geometry and Interference Connection


Reference is now made to FIG. 6, illustrating a close-up cross-sectional view of an exemplary geometry and interference connection of a proximal portion of a unitary mounting frame with a proximal portion of a cartridge, in accordance with some embodiments of the invention.


Illustrated is a perspective view of an exemplary proximal connector structure, showing interference elements and snaps for mounting a cartridge to a receiving frame. Optionally snaps and/or fittings and/or pins may be molded into the cartridge. For example fittings may include a plastic snap, a rivet, a pin, a cut out, an indentation, a protuberance, snap clamps, a catch, a ball fitting, a latch, a barb etc.


In some embodiments, two interference elements are provided, for example interference elements 332. It should be noted that the view illustrated in FIG. 6 shows only one interference element 332, but another one is found on the opposite side not shown in this view. This is applicable to all other components which are mentioned herein to include two members, but showing only one, unless mentioned otherwise.


In some embodiments, interference elements 332 are shaped to have a cavity shape by covering three sides of pins 425. For example, the bottom side is covered by the receiving frame's floor 111, optionally in an offset position to the fitting from other directions, as in some embodiments, the mounting pin 425 extends along the entire length of the cartridge proximal side through connection 427, as shown in FIG. 4. The top side is, for example, covered by an overhanging portion of interference elements 332 which overhangs mounting pin 425. The distal side of the mounting pin 425 is, for example, covered with distal stop 333, which in some embodiments comprised of a distal mechanically interfering wall, optionally part of interfering element 332.


In some embodiments, for example, two snaps 334 latch to pins 425 to hold the proximal end of cartridge 120 to a receiving frame 110. Optionally latches 334 are flexible plastic. As cartridge 120 is lowered onto receiving frame 110, pins 425, for example see FIG. 5, pushes latches 334 downwards, for example by elastically bending plastic latches 334. Once cartridge 120 is in place, latches 334 snap back to secure pins 425 from their proximal side. Alternatively or additionally, latches 334 may be made of spring steel and/or may be rigid and held by a pivot and/or spring etc.


Illustrated in FIG. 6 is an exemplary telescoping plunger driver 140. For example, plunger driver may include threaded telescoping rods such that when a transmission is rotated (for example by a motor) the telescoping rods expand driving plunger seal 141 into reservoir 410 and/or discharging the pharmaceutical substance out of fluid path 305.


Also illustrated in FIG. 6 are driver mount 315, having containing walls for containing plunger driver 140, and having gap 320 and space 620, which is formed in some embodiments between plunger driver 140 and the proximal wall of driver mount 315, and is optionally filled with cover extension 512.


Exemplary Planar Configuration


Reference is now made to FIG. 7, illustrating a perspective top view of an exemplary side-by-side configuration of the cartridge and the driving system of the cartridge, in accordance with some embodiments of the invention.


In some embodiments, cartridge 120, plunger driver 140 and motor 170 are provided side by side on top of receiving frame 110, potentially reducing the height of the injector, potentially leading to an injector being held more easily by an injection subject and/or a caregiver. In some embodiments, the components are arranged in proximity to one another, potentially dissipating forces in proximity to their generation site by the containing structure of receiving frame 110.


Exemplary Cartridge Proximal Fitting


Reference is now made to FIGS. 8A and 8B, illustrating a side view of a snap fitting and immobilization of a cartridge, in accordance with some embodiments of the invention, wherein FIG. 8A illustrates a cross-sectional view of FIG. 8B illustrates a partial perspective view.



FIG. 8A illustrates a wide view of a side cross-section of the receiving frame 110, mounted with cartridge 120. Illustrated are distal mount 325 and proximal mounting assembly, comprising interference elements 332 and snaps 334. In some embodiments, the containing compartment 315 of plunger driver is positioned in proximity to the proximal end of cartridge 120.



FIG. 8B illustrates the proximal mechanical proximity of cartridge 120 with plunger driver 140, when they are mechanically coupled through plunger 141 residing in reservoir 410. Also shown in FIG. 8B is the proximity of the proximal fitting assembly of cartridge 120 with receiving frame 110, comprising for example mounting pins 425 surrounded by interference elements 332, distal stop 333 and snaps 334. A potential advantage of providing a securing assembly such as the proximal fitting assembly in proximity to the plunger driver is by dissipating the forces near their generation site where they affect the most, and potentially reducing the propagation of the forces into less secured or sturdy regions of the cartridge.


Exemplary Incorporation of a Cover Extension


Reference is now made to FIG. 9, illustrating a cross-sectional side view of the automatic injector, illustrating an incorporation of a cover extension in the immobilization system, in accordance with some embodiments of the invention.


In some embodiments, gap 320 is utilized for receiving the proximal end of plunger driver 140 before it is shifted distally by sliding being mechanically coupled to cartridge 120, through plunger 141. Shown in FIG. 9 is gap filling by extension 512 of cover 510. In some embodiments, extension 512 provides mechanical contra for the force exerted by the proximal portion of plunger driver 140, which results from extending the threaded telescoping rod system of plunger driver 140. In some embodiments, extension 512 prevents plunger driver 140 from shifting in a proximal direction, and enables plunger 141 to be pushed in a distal direction.


Exemplary Cartridge Distal Fitting


Reference is now made to FIG. 10, illustrating a bottom perspective view of an exemplary unitary mounting frame, showing a distal fitting with a cartridge, in accordance with some embodiments of the invention.


In some embodiments, a frame floor 111 serves as a base structure of receiving frame 110, and giving mechanical support for the complementary and/or containing geometry of receiving frame 110, and also connecting between the geometrical features. FIG. 10 shows a bottom view of the geometrical features as positioned on floor 111.


Shown in FIG. 10, for example, is distal mounting pin 422 fitted with distal mount 325. In some embodiments, distal mount 325 comprises a cavity sized for insertion of pin 422. Optionally, distal mount 325 covers at least the top portion of pin 422, potentially balancing mechanical forces reaching from the ventral direction from inserting the needle 116 into an injection subject. In some embodiments, distal mount 325 also secures cartridge 120 by mechanically inhibiting further distal movement of the cartridge with respect to receiving frame 110.


Also shown in FIG. 10 is a bottom view of snaps 334. In some embodiments, the floor 111 of receiving frame 110 is continuous at least between the proximal end of the driving system and the distal end of the cartridge, serving as a wide mechanical platform base. Alternatively, and as exemplified in FIG. 10, floor 111 is not continuous and comprises apertures. Optionally, at least the proximal end and/or at least the distal end include continuous regions of floor 111. A potential advantage of splitting the continuous regions is that each region would contain forces generated in proximity to it, and the forces would propagate less to other regions.


Exemplary Dimensions of a Drug Delivery Device


In some embodiments the payload of a reservoir (for example a syringe) may include, for example between 0.5 and 2 ml and/or between 2 and 4 ml and/or between 4 and 6 ml and/or between 4 and 10 ml of a drug and/or more. In some embodiments, the injector may discharge the entire payload as a single dose. A drug delivery device may include, for example, a patch injector, and/or an internally powered driver to drive the plunger and/or discharge the payload. For the sake of this application an internally powered injector driver may be defined as a drive mechanism powered by energy stored at least temporarily within the injector. Power may be stored in a power supply, for instance as chemical potential (for example a chemical that produces an expanding gas and/or a battery) and/or mechanical potential (for example stored in an elastic member and/or a spring and/or a pressurized gas). For example the driver may be designed to discharge the payload over a time period ranging between 20 and 120 seconds and/or between 120 and 600 seconds and/or between 600 seconds and an hour and/or between an hour and a day and/or longer.


In general, discharge may be driven by a driver. An internally powered driver may be powered by various mechanisms including for example a motor as discussed, including for example a DC motor, an actuator, a brushless motor, and/or a transmission including for example a telescoping assembly and/or a threaded element and/or a gear and/or a coupling and/or an elastic mechanism (for example a spring and/or a rubber band) and/or an expanding gas and/or a hydraulic actuator).


A drug delivery device in accordance with some embodiments of the present invention may include a reservoir part as discussed. For example a reservoir may include a medicine container and/or a syringe. Optionally a syringe may be preloaded with medicine using standard equipment and/or in an aseptic room. A preloaded syringe may optionally include a proximal opening. A plunger may optionally seal the proximal opening and/or protect the sterility of the contents of the syringe. A sterile needle, typically hollow, may optionally be connected to the syringe barrel. For example, the hollow of the needle may be in fluid communication with the interior of the barrel.


The needle may optionally be rigidly attached to the extension at the distal end of the barrel. The sterility of all and/or part of the needle may for example be protected by a sterile cover. The sterile cover may remain on the needle when the syringe is supplied and/or installed into an injector. For example, the medicine container may optionally include a cylindrical barrel rigidly attached to a needle. In some embodiments a plunger may slide axially along the inside of the barrel to discharge a medicine payload. For example, the medicine may be discharged through the hollow needle. The protruding tip of the needle may be oriented at an angle to the axis of the barrel.


An aspect ratio of the base may be defined as the ratio of the length of the longest axis of the base to the shortest axis. Optionally the axis ratio may range between 1 to 1.5 and/or 1.5 to 2 and/or between 2 to 3 and/or greater than 3. In some embodiments, the height of the injector may range between half the length of the short axis of the base to the length of the short axis of the base and/or between the length of the short axis of the base to twice the length of the short axis of the base and/or greater than the twice length of the short axis of the base. The height of the injector may supply leverage for pivoting the adhesive off the skin of a patient after use.


In some embodiments, the force to insert the needle to the skin of a patient may range for example between 0.02 to 0.2 N and/or between 0.2 and 0.5 N and/or between 0.5 to 5 N. Optionally, the force required to inject the drug (for example the force on a syringe plunger) may range for example between 5 to 60 N. For example the force required to inject the drug may depend on the injection rate and/or the viscosity of the drug and/or the syringe geometry and/or the needle dimensions.


In some embodiments a needle protection mechanism may be triggered by a linear force greater than, for example, between 10 to 60 N.


For example, drug delivery device may include an auto-injector. The auto-injector may be activated by manually pushing with enough force to insert the needle. The device may then apply an injection force to inject a drug. Once the entire drug is injected and/or when there is an obstruction and/or occlusion, the injection force may rise until it passes a threshold triggering safeguarding of the needle and/or ending injection.


For example in the event of an occlusion and/or at the end of delivery, the linear force generated by the device may increase to the level of up to 60 N. A needle safeguarding mechanism (for example a needle retraction mechanism) may be sensitive to the force. For example the mechanism may include a snap that gives way at 40 N returning the needle to the retracted position.


In some embodiments, the stress to inject a medicine and/or to trigger safeguarding of a needle may include a torque. For example, injection of medicine may be driven by a plunger. The plunger may optionally be driven by a threaded assembly, for example a threaded screw and/or teeth and/or a telescoping assembly. Optionally the pitch of the teeth and/or an associated screw may range for example between 0.5 and 2 mm. The diameter of the screw may range for example between 2.5 and 15 mm. The torque to power injection may range for example between 0.2 and 1.0 N-cm. The trigger torque (the torque at which the needle safeguarding is triggered) may range for example between to 0.5 to 2 and/or from 2 to 4 and/or from 4 to 10 N-cm.


During injection, the linear movement of a plunger may range for example between 10-50 mm. The length of movement of the plunger may vary for example with the volume of medicine to be injected that may range for example between 0.5 to 3 ml.


In some embodiments, a safeguarding mechanism may be sensitive to a torque. For example, the needle may be retracted when the mechanism is exposed to a twisting moment. Optionally, discharge may be driven by a torque. For example the driver may apply torque to threaded element pushing a plunger. When the torque on the driver reaches a threshold value, the needle may be released and/or retracted and/or a needle shield may be deployed. Alternatively or additionally the trigger mechanism may require both a torque and a linear force. For example, requiring both a torque and a linear stress may prevent premature activation due to momentary friction.


In some embodiments the reservoir may have a length ranging for example between 20 and 42 and/or 42 and 48 mm and/or 48 and 80 mm and/or 80 and 200 mm. In some embodiments an internal cylindrical space of a reservoir may have an average width ranging for example between 1 and 3 mm and/or 3 and 10 and/or 10 and 15 mm and/or 15 and 25 mm and/or 25 and 50 mm. Optionally a reservoir may have a circular cross section such that width is the diameter of the circle. In some embodiments an extension may have a straight end portion with a length ranging for example between 1 and 3 mm or 3 and 7 mm or 7 and 8 or 8 and 10 mm or 10 and 15 mm or 15 and 50 mm. In some embodiments the exposed straight portion of a needle may have a length ranging for example between 1 and 5 mm or 5 and 7 mm or 7 and 10 mm or 10 and 20 mm.


For a non-uniform cross section an average outer width may be defined as the width of the smallest oval that can enclose the neck averaged over the length of the neck. In some embodiments a fluid path between the extension and a reservoir cavity may include a 27 gauge needle or a needle ranging between 25 and 30 gauge or a needle ranging between 20 and 25 gauge or a needle ranging between 30 and 32 gauge. In some embodiments a needle protruding from an extension may include a 27 gauge needle or a needle ranging between 25 and 30 gauge or a needle ranging between 20 and 25 gauge or a needle ranging between 30 and 32 gauge.


General


As used herein the term “about” refers to ±25%.


The terms “comprises”, “comprising”, “includes”, “including”, “having” and their conjugates mean “including but not limited to”.


The term “consisting of means” “including and limited to”.


The term “consisting essentially of” means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.


As used herein, the singular form “a”, “an” and “the” include plural references unless the context clearly dictates otherwise.


Throughout this application, various embodiments of this invention may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.


Whenever a numerical range is indicated herein, it is meant to include any cited numeral (fractional or integral) within the indicated range. The phrases “ranging/ranges between” a first indicate number and a second indicate number and “ranging/ranges from” a first indicate number “to” a second indicate number are used herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numerals therebetween.


It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.


Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.


All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.

Claims
  • 1. A receiving frame for immobilizing a cartridge to an automatic injector housing, the cartridge including a connection feature and a needle at a distal end of said cartridge, the cartridge being mechanically coupled at a proximal end of said cartridge to a plunger driver, the receiving frame comprising: a ventral side configured to fit into a base portion of said automatic injector housing; anda dorsal side including: a cartridge mount configured to receive said cartridge from a first direction perpendicular to a longitudinal axis of the receiving frame, the cartridge mount configured to latch the cartridge in place after said cartridge is received from the first direction and slide in a second direction parallel to the longitudinal axis of the receiving frame, said cartridge mount comprising: an interference element with a distal stop, wherein the interference element is sized to slidably link to said connection feature and allow said cartridge to slide in the second direction up to said distal stop; anda snap element that allows the interference element to receive the connection feature, wherein the snap element is configured to inhibit disconnection of said cartridge from said interference element after the cartridge is received in the first direction, slid in the second direction, and latched in place; anda driver mount configured to fixedly contain said plunger driver, said driver mount comprising a walled container sized to at least partially surround said plunger driver and defining an open top for receiving said plunger driver,wherein said cartridge and said driver mount are configured to be mechanically coupled through said plunger driver.
  • 2. The receiving frame of claim 1, further comprising a motor mount, configured to fixedly contain a motor in operable communication with the plunger driver, said motor mount comprising a walled container sized to at least partially surround said motor and defining an open top for receiving said motor.
  • 3. The receiving frame of claim 2, wherein said cartridge mount, said driver mount, and said motor mount are a unitary piece.
  • 4. The receiving frame of claim 2, wherein a longitudinal axes of each of said cartridge, said plunger driver, and said motor are configured to be positioned on a same plane.
  • 5. The receiving frame of claim 1, wherein said driver mount contains forces of at least 20 kg-cm.
  • 6. The receiving frame of claim 1, wherein said interference element is shaped to surround a portion of said cartridge from a dorsal, a distal, and a ventral side of said portion of said cartridge.
  • 7. The receiving frame of claim 1, wherein the snap element is configured to elastically deflect during slidable engagement of the connection feature of the cartridge with the interference element of the cartridge mount and to subsequently release to snap back, immobilize and inhibit disconnection of the cartridge from the cartridge mount.
  • 8. The receiving frame of claim 1, wherein the interference element is sized to allow said cartridge to slide up to said distal stop along the second direction, and the distal stop and the snap element are together configured to inhibit movement of the connection feature of the cartridge along the second direction.
  • 9. The receiving frame of claim 8, wherein the snap element is configured to elastically deflect during sliding of the cartridge within the interference element in the second direction and to subsequently release to snap back and immobilize disconnection of the cartridge from the interference element.
  • 10. The receiving frame of claim 1, wherein the snap element is elastic.
RELATED APPLICATION

This application is a divisional application of similarly-titled, co-pending U.S. application Ser. No. 16/071,574, filed Jul. 20, 2018, which is a section 371 of International Application No. PCT/US16/68371, filed Dec. 22, 2016, which was published in the English language on Jul. 27, 2017 under International Publication No. WO 2017/127216 A1, which claims the benefit of U.S. Provisional Application No. 62/281,536, filed Jan. 21, 2016, the disclosures of each which are incorporated herein by reference in their entirety.

US Referenced Citations (905)
Number Name Date Kind
232432 Allison Sep 1880 A
1125887 Schimmel Jan 1915 A
1321550 Platt Nov 1919 A
1704921 Nicoll Mar 1929 A
1795530 Cowan et al. Mar 1931 A
1795630 Wilson Mar 1931 A
2453590 Poux Nov 1948 A
2589426 Ogle Mar 1952 A
2677373 George May 1954 A
2702547 Glass Feb 1955 A
2860635 Wilburn Nov 1958 A
3203269 Perrine Aug 1965 A
3212685 James et al. Oct 1965 A
3585439 Schneeberger Jun 1971 A
3623474 Heilman et al. Nov 1971 A
3705582 Stumpf et al. Dec 1972 A
3708945 Klettke Jan 1973 A
3794028 Mueller et al. Feb 1974 A
3834387 Brown Sep 1974 A
3994295 Wulff Nov 1976 A
4085747 Lee Apr 1978 A
4189065 Herold Feb 1980 A
4195636 Behnke Apr 1980 A
4218724 Kaufman Aug 1980 A
4254768 Ty Mar 1981 A
4273122 Whitney et al. Jun 1981 A
4300554 Hessberg et al. Nov 1981 A
4324262 Hall Apr 1982 A
4403987 Gottinger Sep 1983 A
4425120 Sampson et al. Jan 1984 A
4435173 Siposs et al. Mar 1984 A
4465478 Sabelman et al. Aug 1984 A
4502488 Degironimo et al. Mar 1985 A
4504263 Steuer et al. Mar 1985 A
4549554 Markham Oct 1985 A
4564054 Gustavsson Jan 1986 A
4565543 Bekkering et al. Jan 1986 A
4583974 Kokernak Apr 1986 A
4585439 Michel Apr 1986 A
4599082 Grimard Jul 1986 A
4601702 Hudson Jul 1986 A
4636201 Ambrose et al. Jan 1987 A
4664654 Strauss May 1987 A
4685903 Cable et al. Aug 1987 A
4695274 Fox Sep 1987 A
4698055 Sealfon Oct 1987 A
4702738 Spencer Oct 1987 A
4704105 Adorjan et al. Nov 1987 A
4710178 Henri et al. Dec 1987 A
4729208 Galy et al. Mar 1988 A
4735311 Lowe et al. Apr 1988 A
4737144 Choksi Apr 1988 A
4772272 Mcfarland Sep 1988 A
4810215 Kaneko Mar 1989 A
4810249 Haber et al. Mar 1989 A
4813426 Haber et al. Mar 1989 A
4840185 Hernandez Jun 1989 A
4850966 Grau et al. Jul 1989 A
4861341 Woodburn Aug 1989 A
4863434 Bayless Sep 1989 A
4867743 Vaillancourt Sep 1989 A
4874383 Mcnaughton Oct 1989 A
4882575 Kawahara Nov 1989 A
4886499 Cirelli et al. Dec 1989 A
4892521 Laico et al. Jan 1990 A
4897083 Martell Jan 1990 A
4900310 Ogle, II Feb 1990 A
4915702 Haber Apr 1990 A
4919569 Wittenzellner Apr 1990 A
4919596 Slate et al. Apr 1990 A
4923446 Page et al. May 1990 A
4929241 Kulli May 1990 A
4950241 Ranford Aug 1990 A
4950246 Muller Aug 1990 A
4957490 Byrne et al. Sep 1990 A
4964866 Szwarc Oct 1990 A
4994045 Ranford Feb 1991 A
4998924 Ranford Mar 1991 A
5019051 Hake May 1991 A
5051109 Simon Sep 1991 A
5062828 Waltz Nov 1991 A
D322671 Szwarc Dec 1991 S
5088988 Talonn et al. Feb 1992 A
5109850 Blanco et al. May 1992 A
5112317 Michel May 1992 A
5114406 Gabriel et al. May 1992 A
5127910 Talonn et al. Jul 1992 A
5131816 Brown et al. Jul 1992 A
5147326 Talonn et al. Sep 1992 A
5156599 Ranford et al. Oct 1992 A
5190521 Hubbard et al. Mar 1993 A
5217437 Talonn et al. Jun 1993 A
5246670 Haber et al. Sep 1993 A
5254096 Rondelet et al. Oct 1993 A
5267977 Feeney, Jr. Dec 1993 A
5269762 Armbruster et al. Dec 1993 A
5275582 Wimmer Jan 1994 A
5282593 Fast Feb 1994 A
5295966 Stern et al. Mar 1994 A
5298023 Haber et al. Mar 1994 A
5300045 Plassche, Jr. Apr 1994 A
5318522 D'Antonio Jun 1994 A
5338311 Mahurkar Aug 1994 A
5342313 Campbell et al. Aug 1994 A
5348544 Sweeney et al. Sep 1994 A
5366498 Brannan et al. Nov 1994 A
5376785 Chin et al. Dec 1994 A
5383865 Michel Jan 1995 A
D356150 Duggan et al. Mar 1995 S
5415645 Friend et al. May 1995 A
5456360 Griffin Oct 1995 A
5478315 Brothers et al. Dec 1995 A
5478316 Bitdinger et al. Dec 1995 A
5482446 Williamson et al. Jan 1996 A
5496274 Graves et al. Mar 1996 A
5501665 Jhuboo et al. Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
5562624 Righi et al. Oct 1996 A
5562686 Sauer et al. Oct 1996 A
5593390 Castellano et al. Jan 1997 A
5609580 Kwiatkowski et al. Mar 1997 A
5611785 Mito et al. Mar 1997 A
5616132 Newman Apr 1997 A
5624400 Firth et al. Apr 1997 A
5637095 Nason et al. Jun 1997 A
5643218 Lynn et al. Jul 1997 A
5645530 Boukhny et al. Jul 1997 A
5645955 Maglica Jul 1997 A
5647853 Feldmann et al. Jul 1997 A
5658256 Shields Aug 1997 A
5662678 Macklin Sep 1997 A
5672160 Oesterlind et al. Sep 1997 A
5690618 Smith et al. Nov 1997 A
5697908 Imbert et al. Dec 1997 A
5697916 Schraga Dec 1997 A
5725500 Micheler Mar 1998 A
5728075 Levander Mar 1998 A
D393314 Meisner et al. Apr 1998 S
5741275 Wyssmann Apr 1998 A
5766186 Faraz et al. Jun 1998 A
5776103 Kriesel et al. Jul 1998 A
5795675 Maglica Aug 1998 A
5800420 Gross et al. Sep 1998 A
5807375 Gross et al. Sep 1998 A
5810167 Fujii Sep 1998 A
5810784 Tamaro Sep 1998 A
5814020 Gross Sep 1998 A
5830187 Kriesel et al. Nov 1998 A
5836920 Robertson Nov 1998 A
5848991 Gross et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5858008 Capaccio Jan 1999 A
5868710 Battiato et al. Feb 1999 A
5893842 Imbert Apr 1999 A
5894015 Rechtin Apr 1999 A
5919167 Mulhauser et al. Jul 1999 A
5926596 Edwards et al. Jul 1999 A
5931814 Alex et al. Aug 1999 A
5941850 Shah et al. Aug 1999 A
5944699 Barrelle et al. Aug 1999 A
5948392 Haslwanter et al. Sep 1999 A
5954697 Srisathapat et al. Sep 1999 A
5957895 Sage et al. Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5989221 Hjertman Nov 1999 A
5993423 Choi Nov 1999 A
6004296 Jansen et al. Dec 1999 A
6004297 Steenfeldt-Jensen et al. Dec 1999 A
6033245 Yamkovoy Mar 2000 A
6033377 Rasmussen et al. Mar 2000 A
6045533 Kriesel et al. Apr 2000 A
6064797 Crittendon et al. May 2000 A
6074369 Sage et al. Jun 2000 A
6162197 Mohammad Dec 2000 A
6186979 Dysarz Feb 2001 B1
6186982 Gross et al. Feb 2001 B1
6189292 Odell et al. Feb 2001 B1
6200289 Hochman et al. Mar 2001 B1
6200296 Dibiasi et al. Mar 2001 B1
6224569 Brimhall May 2001 B1
6248093 Moberg Jun 2001 B1
6270481 Mason et al. Aug 2001 B1
6277095 Kriesel et al. Aug 2001 B1
6277098 Klitmose et al. Aug 2001 B1
6277099 Strowe et al. Aug 2001 B1
6287283 Ljunggreen et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302633 Poe Oct 2001 B1
6336729 Pavelle et al. Jan 2002 B1
6345968 Shupe Feb 2002 B1
6377848 Garde et al. Apr 2002 B1
6391005 Lum et al. May 2002 B1
6423029 Elsberry Jul 2002 B1
D461243 Niedospial Aug 2002 S
D465026 May et al. Oct 2002 S
6458102 Mann et al. Oct 2002 B1
6485461 Mason et al. Nov 2002 B1
6485465 Moberg et al. Nov 2002 B2
6500150 Gross et al. Dec 2002 B1
6503231 Prausnitz et al. Jan 2003 B1
6511336 Turek et al. Jan 2003 B1
6517517 Farrugia et al. Feb 2003 B1
D471274 Diaz et al. Mar 2003 S
D471983 Hippolyte et al. Mar 2003 S
6554800 Nezhadian et al. Apr 2003 B1
6558351 Steil et al. May 2003 B1
6565541 Sharp May 2003 B2
6589229 Connelly et al. Jul 2003 B1
6595956 Gross et al. Jul 2003 B1
6595960 West et al. Jul 2003 B2
6645181 Lavi et al. Nov 2003 B1
6652482 Hochman Nov 2003 B2
6656158 Mahoney et al. Dec 2003 B2
6656159 Flaherty Dec 2003 B2
6659980 Moberg et al. Dec 2003 B2
6673033 Sciulli et al. Jan 2004 B1
6679862 Diaz et al. Jan 2004 B2
6685678 Evans et al. Feb 2004 B2
6689118 Alchas et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6719141 Heinz et al. Apr 2004 B2
6722916 Buccinna et al. Apr 2004 B2
6743211 Prausnitz et al. Jun 2004 B1
6749587 Flaherty Jun 2004 B2
6752783 Hung et al. Jun 2004 B2
6752787 Causey et al. Jun 2004 B1
6767336 Kaplan Jul 2004 B1
6768425 Flaherty et al. Jul 2004 B2
6786890 Preuthun et al. Sep 2004 B2
6800071 Mcconnell et al. Oct 2004 B1
6805687 Dextradeur et al. Oct 2004 B2
6824529 Gross et al. Nov 2004 B2
6843782 Gross et al. Jan 2005 B2
6854620 Ramey Feb 2005 B2
6905298 Haring Jun 2005 B1
6907679 Yarborough et al. Jun 2005 B2
6908452 Diaz et al. Jun 2005 B2
6960192 Flaherty et al. Nov 2005 B1
6979316 Rubin et al. Dec 2005 B1
6997727 Legrady et al. Feb 2006 B1
7001360 Veasey et al. Feb 2006 B2
7004104 Kundus Feb 2006 B1
7004929 McWethy et al. Feb 2006 B2
7025226 Ramey Apr 2006 B2
7033338 Vilks et al. Apr 2006 B2
7034223 Fan et al. Apr 2006 B2
7048715 Diaz et al. May 2006 B2
7060054 Nissels Jun 2006 B2
7060059 Keith et al. Jun 2006 B2
7066909 Peter et al. Jun 2006 B1
7094221 Veasey et al. Aug 2006 B2
7097637 Triplett et al. Aug 2006 B2
7112187 Karlsson Sep 2006 B2
7128727 Flaherty et al. Oct 2006 B2
7144384 Gorman et al. Dec 2006 B2
D544092 Lewis Jun 2007 S
7225694 Said Jun 2007 B2
7247149 Beyerlein Jul 2007 B2
7250037 Shermer et al. Jul 2007 B2
7267669 Staunton et al. Sep 2007 B2
RE39923 Blom Nov 2007 E
7291132 Deruntz et al. Nov 2007 B2
7291159 Schmelzeisen-Redeker et al. Nov 2007 B2
7303549 Flaherty et al. Dec 2007 B2
7326194 Zinger et al. Feb 2008 B2
7344385 Chen Mar 2008 B2
7364570 Gerondale et al. Apr 2008 B2
7377912 Graf et al. May 2008 B2
7390312 Barrelle Jun 2008 B2
7390314 Stutz et al. Jun 2008 B2
7407493 Cane Aug 2008 B2
7418880 Smith Sep 2008 B1
D578210 Muta et al. Oct 2008 S
7442186 Blomquist Oct 2008 B2
7455663 Bikovsky Nov 2008 B2
7465290 Reilly Dec 2008 B2
7468055 Prais et al. Dec 2008 B2
7488181 Van Feb 2009 B2
7497842 Diaz et al. Mar 2009 B2
7500963 Westbye et al. Mar 2009 B2
7501587 English Mar 2009 B2
7503786 Kato et al. Mar 2009 B2
7530964 Lavi et al. May 2009 B2
7540858 Dibiasi Jun 2009 B2
7547281 Hayes et al. Jun 2009 B2
7565208 Harris et al. Jul 2009 B2
7569050 Moberg et al. Aug 2009 B2
D600341 Loerwald Sep 2009 S
7585287 Bresina et al. Sep 2009 B2
7588559 Aravena et al. Sep 2009 B2
7589974 Grady et al. Sep 2009 B2
D602155 Foley et al. Oct 2009 S
D602586 Foley et al. Oct 2009 S
D604835 Conley Nov 2009 S
7611491 Pickhard Nov 2009 B2
7628770 Ethelfeld Dec 2009 B2
7628772 Mcconnell et al. Dec 2009 B2
7628782 Adair et al. Dec 2009 B2
7637891 Wall Dec 2009 B2
7637899 Woolston et al. Dec 2009 B2
7641649 Moberg et al. Jan 2010 B2
7660627 Mcnichols et al. Feb 2010 B2
7678079 Shermer et al. Mar 2010 B2
7682338 Griffin Mar 2010 B2
7686787 Moberg et al. Mar 2010 B2
7699829 Harris et al. Apr 2010 B2
7699833 Moberg et al. Apr 2010 B2
7704088 Sakamoto Apr 2010 B2
7704227 Moberg et al. Apr 2010 B2
7704229 Moberg et al. Apr 2010 B2
7704231 Pongpairochana et al. Apr 2010 B2
7708717 Estes et al. May 2010 B2
7713238 Mernoe May 2010 B2
7713240 Istoc et al. May 2010 B2
7717903 Estes et al. May 2010 B2
7717913 Novak et al. May 2010 B2
7722574 Toman et al. May 2010 B2
7736333 Gillespie, III Jun 2010 B2
7736344 Moberg et al. Jun 2010 B2
7744589 Mounce et al. Jun 2010 B2
7749194 Edwards et al. Jul 2010 B2
7758548 Gillespie et al. Jul 2010 B2
7758550 Bollenbach et al. Jul 2010 B2
7766867 Lynch et al. Aug 2010 B2
7776030 Estes et al. Aug 2010 B2
7780637 Jerde et al. Aug 2010 B2
7789857 Moberg et al. Sep 2010 B2
7794426 Briones et al. Sep 2010 B2
7794427 Estes et al. Sep 2010 B2
7801599 Young et al. Sep 2010 B2
7806868 De et al. Oct 2010 B2
7828528 Estes et al. Nov 2010 B2
7837659 Bush et al. Nov 2010 B2
7846132 Gravesen et al. Dec 2010 B2
7854723 Hwang et al. Dec 2010 B2
7857131 Vedrine Dec 2010 B2
7879025 Jacobson et al. Feb 2011 B2
7901382 Daily et al. Mar 2011 B2
7905867 Veasey et al. Mar 2011 B2
7918825 O'Connor et al. Apr 2011 B2
7935104 Yodfat et al. May 2011 B2
7935105 Miller et al. May 2011 B2
7938803 Mernoe et al. May 2011 B2
7955305 Moberg et al. Jun 2011 B2
7967784 Pongpairochana et al. Jun 2011 B2
7967795 Cabiri Jun 2011 B1
7976514 Abry et al. Jul 2011 B2
7981105 Adair et al. Jul 2011 B2
7988683 Adair et al. Aug 2011 B2
7993300 Nyholm et al. Aug 2011 B2
7993301 Boyd et al. Aug 2011 B2
7998111 Moberg et al. Aug 2011 B2
8002754 Kawamura et al. Aug 2011 B2
8021357 Tanaka et al. Sep 2011 B2
8025658 Chong et al. Sep 2011 B2
8029469 Ethelfeld Oct 2011 B2
8034019 Nair et al. Oct 2011 B2
8038666 Triplett et al. Oct 2011 B2
8057431 Woehr et al. Nov 2011 B2
8057436 Causey et al. Nov 2011 B2
8062253 Nielsen et al. Nov 2011 B2
8062255 Brunnberg et al. Nov 2011 B2
8066694 Wagener Nov 2011 B2
D650079 Presta et al. Dec 2011 S
D650903 Kosinski et al. Dec 2011 S
8086306 Katzman et al. Dec 2011 B2
D652503 Cameron et al. Jan 2012 S
8105279 Mernoe et al. Jan 2012 B2
8105293 Pickhard Jan 2012 B2
8114046 Covino et al. Feb 2012 B2
8114064 Alferness et al. Feb 2012 B2
8114066 Naef et al. Feb 2012 B2
8118781 Knopper et al. Feb 2012 B2
8121603 Zhi Feb 2012 B2
D657462 Siroky Apr 2012 S
8147446 Yodfat et al. Apr 2012 B2
8151169 Bieth et al. Apr 2012 B2
8152764 Istoc et al. Apr 2012 B2
8152770 Reid Apr 2012 B2
8152779 Cabiri Apr 2012 B2
8152793 Keinaenen et al. Apr 2012 B2
8157693 Waksmundzki Apr 2012 B2
8157769 Cabiri Apr 2012 B2
8162674 Cho et al. Apr 2012 B2
8162923 Adams et al. Apr 2012 B2
8167841 Teisen-Simony et al. May 2012 B2
8172591 Wertz May 2012 B2
8172804 Bikovsky May 2012 B2
8177749 Slate et al. May 2012 B2
8182462 Istoc et al. May 2012 B2
8197444 Bazargan et al. Jun 2012 B1
8206351 Sugimoto et al. Jun 2012 B2
8221356 Enggaard et al. Jul 2012 B2
8267921 Yodfat et al. Sep 2012 B2
8287520 Drew et al. Oct 2012 B2
8292647 Mcgrath et al. Oct 2012 B1
8308679 Hanson et al. Nov 2012 B2
8308695 Laiosa Nov 2012 B2
8323250 Chong et al. Dec 2012 B2
8348898 Cabiri Jan 2013 B2
8366668 Maritan Feb 2013 B2
8372039 Mernoe et al. Feb 2013 B2
8373421 Lindegger et al. Feb 2013 B2
8409141 Johansen et al. Apr 2013 B2
8409142 Causey et al. Apr 2013 B2
8409143 Lanigan et al. Apr 2013 B2
8409149 Hommann et al. Apr 2013 B2
8414533 Alexandersson Apr 2013 B2
8414557 Istoc et al. Apr 2013 B2
8425468 Weston Apr 2013 B2
8430847 Mernoe et al. Apr 2013 B2
8465455 Cabiri Jun 2013 B2
8469942 Kow et al. Jun 2013 B2
8474332 Bente et al. Jul 2013 B2
8475408 Mernoe et al. Jul 2013 B2
8479595 Vazquez et al. Jul 2013 B2
8490790 Cocheteux et al. Jul 2013 B2
8495918 Bazargan et al. Jul 2013 B2
8496862 Zelkovich et al. Jul 2013 B2
8512287 Cindrich et al. Aug 2013 B2
8512295 Evans et al. Aug 2013 B2
8517987 Istoc et al. Aug 2013 B2
8517992 Jones Aug 2013 B2
8523803 Favreau Sep 2013 B1
8551046 Causey et al. Oct 2013 B2
8556856 Bazargan et al. Oct 2013 B2
8562364 Lin et al. Oct 2013 B2
8568361 Yodfat et al. Oct 2013 B2
8574216 Istoc et al. Nov 2013 B2
8603026 Favreau Dec 2013 B2
8603027 Favreau Dec 2013 B2
8603028 Mudd et al. Dec 2013 B2
8622966 Causey et al. Jan 2014 B2
8628510 Bazargan et al. Jan 2014 B2
8647303 Cowe Feb 2014 B2
8674288 Hanson et al. Mar 2014 B2
8679060 Mernoe et al. Mar 2014 B2
D702834 Norton et al. Apr 2014 S
8690855 Alderete et al. Apr 2014 B2
8708961 Field et al. Apr 2014 B2
8721603 Lundquist May 2014 B2
8751237 Kubota Jun 2014 B2
8753326 Chong et al. Jun 2014 B2
8753331 Murphy Jun 2014 B2
8764707 Moberg et al. Jul 2014 B2
8764723 Chong et al. Jul 2014 B2
8771222 Kanderian et al. Jul 2014 B2
8777896 Starkweather et al. Jul 2014 B2
8777924 Kanderian et al. Jul 2014 B2
8777925 Patton Jul 2014 B2
8784369 Starkweather et al. Jul 2014 B2
8784370 Lebel et al. Jul 2014 B2
8784378 Weinandy Jul 2014 B2
8790295 Sigg et al. Jul 2014 B1
8795224 Starkweather et al. Aug 2014 B2
8795231 Chong et al. Aug 2014 B2
8795260 Drew Aug 2014 B2
8801668 Ali et al. Aug 2014 B2
8801679 Iio et al. Aug 2014 B2
8810394 Kalpin Aug 2014 B2
8814379 Griffiths et al. Aug 2014 B2
8858508 Lavi et al. Oct 2014 B2
8876778 Carrel Nov 2014 B2
8911410 Ekman et al. Dec 2014 B2
8915882 Cabiri Dec 2014 B2
8915886 Cowe Dec 2014 B2
8920374 Bokelman et al. Dec 2014 B2
8932266 Wozencroft Jan 2015 B2
8979802 Woehr Mar 2015 B2
8986250 Beebe Mar 2015 B2
9011164 Filman et al. Apr 2015 B2
9011387 Ekman et al. Apr 2015 B2
9061104 Daniel Jun 2015 B2
9061110 Avery et al. Jun 2015 B2
9072827 Cabiri Jul 2015 B2
9072845 Hiles Jul 2015 B2
9089475 Fangrow Jul 2015 B2
9089641 Kavazov Jul 2015 B2
9138534 Yodfat et al. Sep 2015 B2
9149575 Cabiri Oct 2015 B2
9173997 Gross et al. Nov 2015 B2
9180248 Moberg et al. Nov 2015 B2
9205199 Kemp et al. Dec 2015 B2
D747799 Norton et al. Jan 2016 S
9233215 Hourmand et al. Jan 2016 B2
9259532 Cabiri Feb 2016 B2
9283327 Hourmand et al. Mar 2016 B2
9308327 Marshall et al. Apr 2016 B2
9314569 Causey et al. Apr 2016 B2
9320849 Smith et al. Apr 2016 B2
9345834 Henley et al. May 2016 B2
9345836 Cabiri et al. May 2016 B2
9350634 Fadell May 2016 B2
9352090 Brereton et al. May 2016 B2
9364606 Cindrich et al. Jun 2016 B2
9381300 Smith et al. Jul 2016 B2
9393365 Cabiri Jul 2016 B2
9421323 Cabiri et al. Aug 2016 B2
9421337 Kemp et al. Aug 2016 B2
9427531 Hourmand et al. Aug 2016 B2
9446196 Hourmand et al. Sep 2016 B2
9452261 Alon Sep 2016 B2
9463280 Cabiri Oct 2016 B2
9463889 Schmitz et al. Oct 2016 B2
9468720 Mudd et al. Oct 2016 B2
9474859 Ekman et al. Oct 2016 B2
9492622 Brereton et al. Nov 2016 B2
9522234 Cabiri Dec 2016 B2
9539384 Servansky Jan 2017 B2
9539388 Causey et al. Jan 2017 B2
9539757 Ramirez et al. Jan 2017 B2
9572926 Cabiri Feb 2017 B2
9572927 Bruggemann et al. Feb 2017 B2
9579471 Carrel et al. Feb 2017 B2
9610407 Bruggemann et al. Apr 2017 B2
9656019 Cabiri et al. May 2017 B2
9656021 Brereton et al. May 2017 B2
9656025 Bostrom et al. May 2017 B2
9707356 Hourmand et al. Jul 2017 B2
9744306 Cowe Aug 2017 B2
9775948 Bechmann et al. Oct 2017 B2
9782545 Gross et al. Oct 2017 B2
9789247 Kamen et al. Oct 2017 B2
9814830 Mernoe et al. Nov 2017 B2
9814839 Eaton Nov 2017 B2
9849242 Henley et al. Dec 2017 B2
9862519 Deutschle et al. Jan 2018 B2
9999722 Yodfat et al. Jun 2018 B2
10010681 Koch et al. Jul 2018 B2
10076356 Hadvary et al. Sep 2018 B2
10143794 Lanigan et al. Dec 2018 B2
10149943 Bar-El et al. Dec 2018 B2
D838367 Norton et al. Jan 2019 S
10166335 Reber et al. Jan 2019 B2
10207051 Cereda et al. Feb 2019 B2
10227161 Auerbach Mar 2019 B2
10232116 Ekman et al. Mar 2019 B2
10258740 Mcloughlin et al. Apr 2019 B2
10376641 Hirschel et al. Aug 2019 B2
10376647 Farris et al. Aug 2019 B2
10434262 Bendek et al. Oct 2019 B2
10576213 Gylleby Mar 2020 B2
10576220 Armes Mar 2020 B2
10583260 Kemp Mar 2020 B2
10603430 Shor et al. Mar 2020 B2
10722645 Kamen et al. Jul 2020 B2
10842942 Iibuchi et al. Nov 2020 B2
20010005781 Bergens et al. Jun 2001 A1
20010018937 Nemoto Sep 2001 A1
20010025168 Gross et al. Sep 2001 A1
20010034502 Moberg et al. Oct 2001 A1
20010041869 Causey et al. Nov 2001 A1
20020010423 Gross et al. Jan 2002 A1
20020016569 Critchlow et al. Feb 2002 A1
20020029018 Jeffrey Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020055711 Lavi et al. May 2002 A1
20020055718 Hunt May 2002 A1
20020065488 Suzuki et al. May 2002 A1
20020107487 Preuthun Aug 2002 A1
20020120186 Keimel Aug 2002 A1
20020123740 Flaherty et al. Sep 2002 A1
20020151855 Douglas et al. Oct 2002 A1
20020161332 Ramey Oct 2002 A1
20020169215 Meng Nov 2002 A1
20030009133 Ramey Jan 2003 A1
20030014018 Giambattista et al. Jan 2003 A1
20030050602 Pettis et al. Mar 2003 A1
20030069518 Daley et al. Apr 2003 A1
20030125671 Aramata et al. Jul 2003 A1
20030135159 Daily et al. Jul 2003 A1
20030160683 Blomquist Aug 2003 A1
20030167039 Moberg Sep 2003 A1
20030171717 Farrugia et al. Sep 2003 A1
20030199825 Flaherty et al. Oct 2003 A1
20030216683 Shekalim Nov 2003 A1
20030236498 Gross et al. Dec 2003 A1
20040000818 Preuthun et al. Jan 2004 A1
20040010207 Flaherty et al. Jan 2004 A1
20040049160 Hsieh et al. Mar 2004 A1
20040049161 Shearn Mar 2004 A1
20040082911 Tiu et al. Apr 2004 A1
20040092873 Moberg May 2004 A1
20040116866 Gorman et al. Jun 2004 A1
20040122359 Wenz et al. Jun 2004 A1
20040122369 Schriver et al. Jun 2004 A1
20040127857 Shemesh et al. Jul 2004 A1
20040135078 Mandro et al. Jul 2004 A1
20040158172 Hancock Aug 2004 A1
20040158205 Savage Aug 2004 A1
20040186419 Cho Sep 2004 A1
20040186441 Graf et al. Sep 2004 A1
20040210196 Bush et al. Oct 2004 A1
20040260233 Garibotto et al. Dec 2004 A1
20050027255 Lavi et al. Feb 2005 A1
20050033234 Sadowski et al. Feb 2005 A1
20050038391 Wittland et al. Feb 2005 A1
20050065466 Vedrine Mar 2005 A1
20050065472 Cindrich et al. Mar 2005 A1
20050071487 Lu et al. Mar 2005 A1
20050113761 Faust et al. May 2005 A1
20050124940 Martin et al. Jun 2005 A1
20050154353 Alheidt Jul 2005 A1
20050159706 Wilkinson et al. Jul 2005 A1
20050171476 Judson et al. Aug 2005 A1
20050171512 Flaherty Aug 2005 A1
20050177136 Miller Aug 2005 A1
20050197650 Sugimoto et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050238507 Diianni et al. Oct 2005 A1
20050245956 Steinemann et al. Nov 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060013716 Nason et al. Jan 2006 A1
20060030816 Zubry Feb 2006 A1
20060036216 Rimlinger et al. Feb 2006 A1
20060095010 Westbye May 2006 A1
20060095014 Ethelfeld May 2006 A1
20060122577 Poulsen et al. Jun 2006 A1
20060124269 Miyazaki et al. Jun 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173439 Thorne et al. Aug 2006 A1
20060184154 Moberg et al. Aug 2006 A1
20060195029 Shults et al. Aug 2006 A1
20060206054 Shekalim Sep 2006 A1
20060206057 Deruntz et al. Sep 2006 A1
20060211982 Prestrelski et al. Sep 2006 A1
20060229569 Lavi et al. Oct 2006 A1
20060264888 Moberg et al. Nov 2006 A1
20060264889 Moberg et al. Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20060264894 Moberg et al. Nov 2006 A1
20060270987 Peter Nov 2006 A1
20060283465 Nickel et al. Dec 2006 A1
20060293722 Slatkine et al. Dec 2006 A1
20070021733 Hansen et al. Jan 2007 A1
20070025879 Vandergaw Feb 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070073228 Mernoe et al. Mar 2007 A1
20070079894 Kraus et al. Apr 2007 A1
20070118405 Campbell et al. May 2007 A1
20070167912 Causey et al. Jul 2007 A1
20070179444 Causey et al. Aug 2007 A1
20070185449 Mernoe Aug 2007 A1
20070197954 Keenan Aug 2007 A1
20070197968 Pongpairochana et al. Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20070233038 Pruitt et al. Oct 2007 A1
20070265568 Tsals et al. Nov 2007 A1
20070282269 Carter et al. Dec 2007 A1
20080021439 Brittingham et al. Jan 2008 A1
20080033367 Haury et al. Feb 2008 A1
20080033369 Kohlbrenner et al. Feb 2008 A1
20080033393 Edwards et al. Feb 2008 A1
20080051711 Mounce et al. Feb 2008 A1
20080051730 Bikovsky Feb 2008 A1
20080059133 Edwards et al. Mar 2008 A1
20080097326 Moberg et al. Apr 2008 A1
20080097381 Moberg et al. Apr 2008 A1
20080097387 Spector Apr 2008 A1
20080108951 Jerde et al. May 2008 A1
20080140006 Eskuri et al. Jun 2008 A1
20080140014 Miller et al. Jun 2008 A1
20080140018 Enggaard et al. Jun 2008 A1
20080147004 Mann et al. Jun 2008 A1
20080167641 Hansen et al. Jul 2008 A1
20080188813 Miller et al. Aug 2008 A1
20080208138 Lim et al. Aug 2008 A1
20080215006 Thorkild Sep 2008 A1
20080215013 Felix-Faure Sep 2008 A1
20080215015 Cindrich et al. Sep 2008 A1
20080243087 Enggaard et al. Oct 2008 A1
20080249473 Rutti et al. Oct 2008 A1
20080262436 Olson Oct 2008 A1
20080269687 Chong et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080274630 Shelton et al. Nov 2008 A1
20080294143 Tanaka et al. Nov 2008 A1
20080306449 Kristensen et al. Dec 2008 A1
20080312601 Cane Dec 2008 A1
20080319383 Byland et al. Dec 2008 A1
20080319416 Yodfat et al. Dec 2008 A1
20090012478 Weston Jan 2009 A1
20090041805 Walker Feb 2009 A1
20090048347 Cohen et al. Feb 2009 A1
20090054750 Jennewine Feb 2009 A1
20090069784 Estes et al. Mar 2009 A1
20090076383 Toews et al. Mar 2009 A1
20090076453 Mejlhede et al. Mar 2009 A1
20090088694 Carter et al. Apr 2009 A1
20090088731 Campbell et al. Apr 2009 A1
20090093763 Gonnelli et al. Apr 2009 A1
20090093792 Gross Apr 2009 A1
20090093793 Gross et al. Apr 2009 A1
20090105650 Wiegel et al. Apr 2009 A1
20090105663 Brand et al. Apr 2009 A1
20090124977 Jensen May 2009 A1
20090143730 De et al. Jun 2009 A1
20090143735 De Polo Jun 2009 A1
20090149830 Spector Jun 2009 A1
20090182277 Carter Jul 2009 A1
20090182284 Morgan Jul 2009 A1
20090204076 Liversidge Aug 2009 A1
20090209896 Selevan Aug 2009 A1
20090234319 Marksteiner Sep 2009 A1
20090240240 Hines et al. Sep 2009 A1
20090253973 Bashan et al. Oct 2009 A1
20090259176 Yairi Oct 2009 A1
20090281585 Katzman et al. Nov 2009 A1
20090299288 Sie et al. Dec 2009 A1
20090299290 Moberg Dec 2009 A1
20090299397 Ruan et al. Dec 2009 A1
20090326459 Shipway et al. Dec 2009 A1
20090326509 Muse et al. Dec 2009 A1
20100010455 Elahi et al. Jan 2010 A1
20100018334 Lessing Jan 2010 A1
20100030156 Beebe et al. Feb 2010 A1
20100030198 Beebe et al. Feb 2010 A1
20100049128 Mckenzie et al. Feb 2010 A1
20100049144 Mcconnell et al. Feb 2010 A1
20100057057 Hayter et al. Mar 2010 A1
20100076382 Weston Mar 2010 A1
20100076412 Rush et al. Mar 2010 A1
20100094255 Nycz et al. Apr 2010 A1
20100100076 Rush et al. Apr 2010 A1
20100100077 Rush et al. Apr 2010 A1
20100106098 Atterbury et al. Apr 2010 A1
20100121314 Iobbi May 2010 A1
20100137790 Yodrat Jun 2010 A1
20100137831 Tsals Jun 2010 A1
20100145303 Yodfat et al. Jun 2010 A1
20100145305 Alon Jun 2010 A1
20100160894 Julian et al. Jun 2010 A1
20100162548 Leidig Jul 2010 A1
20100168607 Miesel Jul 2010 A1
20100168683 Cabiri Jul 2010 A1
20100198157 Gyrn et al. Aug 2010 A1
20100204657 Yodfat et al. Aug 2010 A1
20100234767 Sarstedt Sep 2010 A1
20100234830 Straessler et al. Sep 2010 A1
20100241065 Moberg et al. Sep 2010 A1
20100256486 Savage Oct 2010 A1
20100264931 Lindegger et al. Oct 2010 A1
20100268169 Llewellyn-Hyde et al. Oct 2010 A1
20100274112 Hoss et al. Oct 2010 A1
20100274192 Mernoe Oct 2010 A1
20100280499 Yodfat et al. Nov 2010 A1
20100331826 Field et al. Dec 2010 A1
20110034900 Yodfat et al. Feb 2011 A1
20110054399 Chong et al. Mar 2011 A1
20110054400 Chong et al. Mar 2011 A1
20110066131 Cabiri Mar 2011 A1
20110092915 Olson et al. Apr 2011 A1
20110112504 Causey et al. May 2011 A1
20110125056 Merchant May 2011 A1
20110160654 Hanson et al. Jun 2011 A1
20110160666 Hanson et al. Jun 2011 A1
20110160669 Gyrn et al. Jun 2011 A1
20110172645 Moga et al. Jul 2011 A1
20110172745 Na et al. Jul 2011 A1
20110178463 Cabiri Jul 2011 A1
20110178472 Cabiri Jul 2011 A1
20110201998 Pongpairochana et al. Aug 2011 A1
20110224616 Slate Sep 2011 A1
20110224646 Yodfat et al. Sep 2011 A1
20110238031 Adair et al. Sep 2011 A1
20110245773 Estes et al. Oct 2011 A1
20110270160 Mernoe Nov 2011 A1
20110282282 Lorenzen et al. Nov 2011 A1
20110282296 Harms et al. Nov 2011 A1
20110295205 Kaufmann et al. Dec 2011 A1
20110313238 Reichenbach et al. Dec 2011 A1
20110319861 Wilk Dec 2011 A1
20110319919 Curry et al. Dec 2011 A1
20120004602 Hanson et al. Jan 2012 A1
20120010594 Holt et al. Jan 2012 A1
20120022344 Kube Jan 2012 A1
20120022496 Causey et al. Jan 2012 A1
20120022499 Anderson et al. Jan 2012 A1
20120029431 Hwang et al. Feb 2012 A1
20120035546 Cabiri Feb 2012 A1
20120041364 Smith Feb 2012 A1
20120041387 Brüggemann et al. Feb 2012 A1
20120041414 Estes et al. Feb 2012 A1
20120071828 Tojo et al. Mar 2012 A1
20120096953 Bente et al. Apr 2012 A1
20120096954 Vazquez et al. Apr 2012 A1
20120101436 Bazargan et al. Apr 2012 A1
20120108933 Liang et al. May 2012 A1
20120109059 Ranalletta et al. May 2012 A1
20120118777 Kakiuchi et al. May 2012 A1
20120123387 Gonzalez May 2012 A1
20120129362 Hampo et al. May 2012 A1
20120160033 Kow et al. Jun 2012 A1
20120165733 Bazargan et al. Jun 2012 A1
20120165780 Bazargan et al. Jun 2012 A1
20120172817 Brüggemann et al. Jul 2012 A1
20120184917 Bom et al. Jul 2012 A1
20120226234 Bazargan et al. Sep 2012 A1
20120238961 Julian et al. Sep 2012 A1
20120259282 Alderete et al. Oct 2012 A1
20130012875 Gross et al. Jan 2013 A1
20130068319 Plumptre et al. Mar 2013 A1
20130085457 Schiff et al. Apr 2013 A1
20130089992 Yang Apr 2013 A1
20130096509 Avery et al. Apr 2013 A1
20130110049 Cronenberg et al. May 2013 A1
20130131589 Mudd et al. May 2013 A1
20130131604 Avery May 2013 A1
20130133438 Kow et al. May 2013 A1
20130172808 Gilbert Jul 2013 A1
20130190693 Ekman et al. Jul 2013 A1
20130200549 Felts et al. Aug 2013 A1
20130204187 Avery et al. Aug 2013 A1
20130204191 Cindrich et al. Aug 2013 A1
20130237953 Kow et al. Sep 2013 A1
20130245595 Kow et al. Sep 2013 A1
20130245596 Cabiri et al. Sep 2013 A1
20130245604 Kouyoumjian et al. Sep 2013 A1
20130253419 Favreau Sep 2013 A1
20130253420 Favreau Sep 2013 A1
20130253421 Favreau Sep 2013 A1
20130253434 Cabiri Sep 2013 A1
20130267895 Hemmingsen Oct 2013 A1
20130296799 Degtiar et al. Nov 2013 A1
20130296824 Mo et al. Nov 2013 A1
20130304021 Cabiri et al. Nov 2013 A1
20130310753 Cabiri Nov 2013 A1
20130323699 Edwards et al. Dec 2013 A1
20130331791 Gross et al. Dec 2013 A1
20130338584 Mounce et al. Dec 2013 A1
20140018735 Causey et al. Jan 2014 A1
20140031747 Ardehali Jan 2014 A1
20140055073 Favreau Feb 2014 A1
20140055076 Favreau Feb 2014 A1
20140058349 Bazargan Feb 2014 A1
20140083517 Moia et al. Mar 2014 A1
20140094755 Bazargan et al. Apr 2014 A1
20140121633 Causey et al. May 2014 A1
20140128807 Moberg et al. May 2014 A1
20140128835 Moberg et al. May 2014 A1
20140135692 Alderete et al. May 2014 A1
20140135694 Moberg et al. May 2014 A1
20140142499 Moberg et al. May 2014 A1
20140148784 Anderson et al. May 2014 A1
20140148785 Moberg et al. May 2014 A1
20140163522 Alderete et al. Jun 2014 A1
20140163526 Cabiri et al. Jun 2014 A1
20140171881 Cabiri Jun 2014 A1
20140174223 Gross et al. Jun 2014 A1
20140194819 Maule et al. Jul 2014 A1
20140194854 Tsals Jul 2014 A1
20140207064 Yavorsky Jul 2014 A1
20140207065 Yavorsky Jul 2014 A1
20140207066 Yavorsky Jul 2014 A1
20140213975 Clemente et al. Jul 2014 A1
20140214001 Mortazavi Jul 2014 A1
20140228768 Eggert et al. Aug 2014 A1
20140236087 Alderete et al. Aug 2014 A1
20140243786 Gilbert Aug 2014 A1
20140261758 Wlodarczyk et al. Sep 2014 A1
20140343503 Holmqvist Nov 2014 A1
20150005703 Hutchinson et al. Jan 2015 A1
20150073344 Van Damme et al. Mar 2015 A1
20150088071 Cabiri Mar 2015 A1
20150112278 Ray et al. Apr 2015 A1
20150119798 Gross et al. Apr 2015 A1
20150157806 Knutsson Jun 2015 A1
20150202375 Schabbach et al. Jul 2015 A1
20150374926 Gross et al. Dec 2015 A1
20160030665 Cabiri Feb 2016 A1
20160051756 Cabiri Feb 2016 A1
20160144117 Chun May 2016 A1
20160151586 Kemp Jun 2016 A1
20160175515 Mccullough Jun 2016 A1
20160184512 Marbet et al. Jun 2016 A1
20160193406 Cabiri Jul 2016 A1
20160199590 Schabbach et al. Jul 2016 A1
20160213840 Schabbach et al. Jul 2016 A1
20160228652 Cabiri et al. Aug 2016 A1
20160296713 Schader et al. Oct 2016 A1
20160296716 Cabiri et al. Oct 2016 A1
20160331900 Wei Nov 2016 A1
20160346478 Bar-El et al. Dec 2016 A1
20160354553 Anderson et al. Dec 2016 A1
20170007774 Brockmeier Jan 2017 A1
20170043092 Murakami et al. Feb 2017 A1
20170058349 Levy et al. Mar 2017 A1
20170175859 Brockmeier Jun 2017 A1
20170246399 Forlani et al. Aug 2017 A1
20170246403 Cowe et al. Aug 2017 A1
20180028765 Waller et al. Feb 2018 A1
20180214637 Kemp et al. Aug 2018 A1
20190022306 Gibson et al. Jan 2019 A1
20190060578 Farris et al. Feb 2019 A1
20190071217 Brown et al. Mar 2019 A1
20190175821 Kamen et al. Jun 2019 A1
20190224415 Dugand et al. Jul 2019 A1
20190240417 Hostettler et al. Aug 2019 A1
20190328968 Giambattista Oct 2019 A1
20200009323 Nair et al. Jan 2020 A1
20200215270 Ogawa et al. Jul 2020 A1
20200297929 Zhang Sep 2020 A1
20210138157 Bar-El et al. May 2021 A1
20210220551 Dowd et al. Jul 2021 A1
Foreign Referenced Citations (213)
Number Date Country
1505535 Jun 2004 CN
1747683 Mar 2006 CN
1863566 Nov 2006 CN
101090749 Dec 2007 CN
101227943 Jul 2008 CN
101448536 Jun 2009 CN
101522235 Sep 2009 CN
101541362 Sep 2009 CN
101641126 Feb 2010 CN
201692438 Jan 2011 CN
201941304 Aug 2011 CN
102186733 Sep 2011 CN
102378638 Mar 2012 CN
105102025 Nov 2015 CN
855313 Nov 1952 DE
1064693 Sep 1959 DE
19518807 Dec 1995 DE
19717107 Nov 1998 DE
0017412 Oct 1980 EP
0222656 May 1987 EP
0401179 Dec 1990 EP
0925082 Jun 1999 EP
1003581 May 2000 EP
1124600 Aug 2001 EP
1219312 Jul 2002 EP
1472477 Nov 2004 EP
1530979 May 2005 EP
1666080 Jun 2006 EP
1372762 Feb 2007 EP
1974759 Oct 2008 EP
2060606 May 2009 EP
2140897 Jan 2010 EP
2173413 Apr 2010 EP
2185227 May 2010 EP
2192935 Jun 2010 EP
2361648 Aug 2011 EP
2364739 Sep 2011 EP
2393534 Dec 2011 EP
2452708 May 2012 EP
2498589 Sep 2012 EP
2574355 Apr 2013 EP
2393535 Mar 2015 EP
2878321 Jun 2015 EP
2886144 Jun 2015 EP
1904130 Mar 2016 EP
2991705 Mar 2016 EP
3266478 Jan 2018 EP
2819724 Mar 2019 EP
2770136 Apr 1999 FR
2436526 Oct 2007 GB
62-112566 May 1987 JP
01-172843 Dec 1989 JP
07-194701 Aug 1995 JP
3035448 Mar 1997 JP
09-505758 Jun 1997 JP
11-507260 Jun 1999 JP
2000-107289 Apr 2000 JP
2000-515394 Nov 2000 JP
2001-512992 Aug 2001 JP
2002-505601 Feb 2002 JP
2002-507459 Mar 2002 JP
2002-528676 Sep 2002 JP
2003-501157 Jan 2003 JP
2003-534061 Nov 2003 JP
2004-501721 Jan 2004 JP
2004-512100 Apr 2004 JP
2003-527138 Aug 2005 JP
2005-523127 Aug 2005 JP
2005-527249 Sep 2005 JP
2005-270629 Oct 2005 JP
2006-507067 Mar 2006 JP
2006-510450 Mar 2006 JP
2006-525046 Nov 2006 JP
2007-509661 Apr 2007 JP
2007-306990 Nov 2007 JP
2008-534131 Aug 2008 JP
2008-220961 Sep 2008 JP
2009-502273 Jan 2009 JP
2009-101093 May 2009 JP
2010-540054 Dec 2010 JP
2010-540156 Dec 2010 JP
2011-136153 Jul 2011 JP
2012-100927 May 2012 JP
4947871 Jun 2012 JP
2013-500811 Jan 2013 JP
2013-505433 Feb 2013 JP
2013-517095 May 2013 JP
2013-519473 May 2013 JP
2013-530778 Aug 2013 JP
2013-531520 Aug 2013 JP
2013-531540 Aug 2013 JP
2014-030489 Feb 2014 JP
2014-515669 Jul 2014 JP
2014-518743 Aug 2014 JP
2015-514486 May 2015 JP
2016-525428 Aug 2016 JP
2016-530016 Sep 2016 JP
9009202 Aug 1990 WO
9307922 Apr 1993 WO
9407553 Apr 1994 WO
9415660 Jul 1994 WO
9513838 May 1995 WO
9609083 Mar 1996 WO
9632975 Oct 1996 WO
9700091 Jan 1997 WO
9710012 Mar 1997 WO
9721457 Jun 1997 WO
9733638 Sep 1997 WO
9857686 Dec 1998 WO
9857683 Dec 1998 WO
9929151 Jun 1999 WO
9938554 Aug 1999 WO
9959665 Nov 1999 WO
0025844 May 2000 WO
2000069509 Nov 2000 WO
0130415 May 2001 WO
0130421 May 2001 WO
0170304 Sep 2001 WO
0172357 Oct 2001 WO
0187384 Nov 2001 WO
0189607 Nov 2001 WO
0189613 Nov 2001 WO
0202165 Jan 2002 WO
0204049 Jan 2002 WO
0234315 May 2002 WO
0238204 May 2002 WO
0256934 Jul 2002 WO
0256943 Jul 2002 WO
0272182 Sep 2002 WO
0362672 Jul 2003 WO
0390833 Nov 2003 WO
2004000397 Dec 2003 WO
2004032990 Apr 2004 WO
2004098684 Nov 2004 WO
2004105841 Dec 2004 WO
2005018703 Mar 2005 WO
2005037350 Apr 2005 WO
2005072795 Aug 2005 WO
2005070485 Aug 2005 WO
2006018617 Feb 2006 WO
2006037434 Apr 2006 WO
2006052737 May 2006 WO
2006069380 Jun 2006 WO
2006102676 Sep 2006 WO
2006104806 Oct 2006 WO
2006121921 Nov 2006 WO
2007017052 Feb 2007 WO
2007051563 May 2007 WO
2007056504 May 2007 WO
2007066152 Jun 2007 WO
2007073228 Jun 2007 WO
2007119178 Oct 2007 WO
2008001377 Jan 2008 WO
2008014908 Feb 2008 WO
2008057976 May 2008 WO
2008072229 Jun 2008 WO
2008076459 Jun 2008 WO
2008078318 Jul 2008 WO
2009019438 Feb 2009 WO
2009022132 Feb 2009 WO
2009043564 Apr 2009 WO
2009044401 Apr 2009 WO
2009046989 Apr 2009 WO
2009043000 Apr 2009 WO
2009069064 Jun 2009 WO
2009125398 Oct 2009 WO
2009144085 Dec 2009 WO
2010078227 Jul 2010 WO
2010078242 Jul 2010 WO
2010089313 Aug 2010 WO
2011075105 Jun 2011 WO
2011090955 Jul 2011 WO
2011090956 Jul 2011 WO
WO 2011101378 Aug 2011 WO
2011110872 Sep 2011 WO
2011124631 Oct 2011 WO
2011129175 Oct 2011 WO
2011131778 Oct 2011 WO
2011131780 Oct 2011 WO
2011131781 Oct 2011 WO
2011133823 Oct 2011 WO
2011156373 Dec 2011 WO
2012003221 Jan 2012 WO
2012032411 Mar 2012 WO
2012040528 Mar 2012 WO
2012145752 Oct 2012 WO
2012160157 Nov 2012 WO
2012168691 Dec 2012 WO
2013036602 Mar 2013 WO
2013058697 Apr 2013 WO
2013115843 Aug 2013 WO
2014132293 Sep 2014 WO
2014179117 Nov 2014 WO
2014179774 Nov 2014 WO
2014194183 Dec 2014 WO
2015048791 Apr 2015 WO
2015048803 Apr 2015 WO
2015078868 Jun 2015 WO
2015091758 Jun 2015 WO
2015091850 Jun 2015 WO
2015114158 Aug 2015 WO
2015114428 Aug 2015 WO
2015118358 Aug 2015 WO
2015163009 Oct 2015 WO
2016087626 Jun 2016 WO
2016087627 Jun 2016 WO
2016141082 Sep 2016 WO
2017022639 Feb 2017 WO
2017161076 Sep 2017 WO
2018222521 Dec 2018 WO
2019224782 Nov 2019 WO
2020120087 Jun 2020 WO
2020193468 Oct 2020 WO
Non-Patent Literature Citations (182)
Entry
Int'l Search Report and Written Opinion dated May 15, 2017 in Int'l Application No. PCT/US2016/068371.
Int'l Preliminary Report on Patentability dated Nov. 22, 2017 in Int'l Application No. PCT/US2016/068371.
Office Action dated Mar. 1, 2018 in EP Application No. 14166592.7.
Office Action dated Mar. 10, 2015 in CN Application No. 201180006567.4.
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 13/643,470 by Alon.
Office Action dated Mar. 30, 2018 in U.S. Appl. No. 14/850,450 by Gross.
Office Action dated Mar. 31, 2015 in JP Application No. 2012-550068.
Office Action dated Mar. 5, 2014 in CN Application No. 200880117084.X.
Office Action dated May 1, 2015 in U.S. Appl. No. 14/638,525 by Filman.
Office Action dated May 13, 2015 in CN Application No. 201380025566.3.
Office Action dated May 14, 2018 in EP Application No. 08808111.2.
Office Action dated May 16, 2012 in U.S. Appl. No. 12/615,828.
Office Action dated May 18, 2018 in EP 14166591.9.
Office Action dated May 23, 2014 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated May 24, 2017 in U.S. Appl. No. 13/874,121, by Degtiar.
Office Action dated May 25, 2021 in Japanese Office Action 2018-538073.
Office Action dated May 3, 2012 in CN Application No. 200880117084.X.
Office Action dated May 31, 2016 in U.S. Appl. No. 14/593,051 by Gross.
Office Action dated May 4, 2017 in CN Application No. 2014101836665.
Office Action dated May 5, 2015 in CN Application No. 201180006571.0.
Office Action dated May 7, 2015 in JP Application No. 2012-550069.
Office Action dated Nov. 10, 2016 in U.S. Appl. No. 13/874,121, by Degtiar.
Office Action dated Nov. 13, 2017 in U.S. Appl. No. 14/193,692, by Gross.
Office Action dated Nov. 2, 2014 in CN Application No. 201180006571.0.
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/429,840 by Cabiri.
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated Nov. 25, 2016 in U.S. Appl. No. 13/874,017, by Cabiri.
Office Action dated Nov. 4, 2013 in EP Application No. 11 709 234.6.
Office Action dated Nov. 5, 2013 in JP Application No. 2010-527595.
Office Action dated Nov. 5, 2014 in U.S. Appl. No. 13/643,470 by Alon.
Office Action dated Nov. 8, 2017 in U.S. Appl. No. 13/874,121, by Degtiar.
Office Action dated Oct. 13, 2020 in Japanese Application No. 2018-538073.
Office Action dated Oct. 2, 2018 in JP Application No. 2018-535062 (Year: 2018).
Office Action dated Oct. 28, 2011 in U.S. Appl. No. 12/615,828.
Office Action dated Oct. 28, 2016 in CN Application No. 2014101783742.
Office Action dated Oct. 5, 2016 in U.S. Appl. No. 13/964,651, by Gross.
Office Action dated Oct. 6, 2017 in U.S. Appl. No. 14/861,478, by Cabiri.
Office Action dated Oct. 9, 2014 in U.S. Appl. No. 13/873,335.
Office Action dated Sep. 18, 2015 in U.S. Appl. No. 13/874,085 by Cabiri.
Office Action dated Sep. 2, 2010 in U.S. Appl. No. 12/244,688 by Gross.
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550068.
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550069.
Office Action dated Sep. 28, 2017 in IN Application No. 2528/DELNP/2010.
Office Action dated Sep. 29, 2013 in CN Application No. 201080040968.7.
Office Action dated Sep. 30, 2010 in U.S. Appl. No. 12/689,250, by Cabiri.
Office Action dated Sep. 30, 2015 in U.S. Appl. No. 13/667,739 by Cabiri.
Office Action dated Sep. 6, 2011 in U.S. Appl. No. 12/345,818.
Office Action dated Sep. 9, 2015 in U.S. Appl. No. 13/643,470 by Alon.
Office Action dated Aug. 17, 2021 in Indian Application No. 201827027625.
Office Action dated Feb. 20, 2015 in U.S. Appl. No. 13/521.181 by Cabiri.
Office Action dated Nov. 6, 2015 in U.S. Appl. No. 14/715,791 by Cabiri.
Int'l Search Report and Written Opinion dated Jul. 31, 2014 in Int'l Application No. PCT/US2014/033598.
Int'l Search Report and Written Opinion dated May 13, 2009 in Int'l Application No. PCT/IL2008/001312.
Int'l Search Report dated Apr. 26, 2010 in Int'l Application No. PCT/US2009/069552.
Int'l Search Report dated Jun. 17, 2011 in Int'l Application No. PCT/US2011/021604.
Int'l Search Report dated Oct. 12, 2011 in Int'l Application No. PCT/US11/21605.
Int'l Search Report dated Sep. 22, 2011 in Int'l Application No. PCT/IL11/00368; Written Opinion.
Int'l Written Opinion dated Jul. 19, 2012 in Int'l Application No. PCT/US11/21605.
Inte'l Search Report and Written Opinion dated Nov. 30, 2016 in Int'l Application No. PCT/US2016/056223.
International Preliminary Report on Patentability and Written Opinion dated Jul. 5, 2011 in International Application No. PCT/US2009/069552.
Notice of Allowance dated Aug. 24, 2015 in U.S. Appl. No. 29/479,307 by Norton.
Offce Action dated Sep. 21, 2010 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Apr. 22, 2016 in CN Application No. 2014102892041.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,688 by Gross.
Office Action dated Aug. 13, 2015 in U.S. Appl. No. 14/553,399 by Cabiri.
Office Action dated Aug. 14, 2017 in CN Application No. 201410178318.9.
Office Action dated Aug. 15, 2013 in CN Application No. 200880117084.X.
Office Action dated Aug. 26, 2014 in CN Application No. 201180006567.4.
Office Action dated Aug. 6, 2014 in EP Appl. No. 11 707 942.6.
Office Action dated Dec. 1, 2015 in CN Application No. 201410289204.1.
Office Action dated Dec. 10, 2013 in CN Application No. 201180006567.4.
Office Action dated Dec. 15, 2017 in U.S. Appl. No. 15/269,248, by Cabiri.
Office Action dated Dec. 17, 2013 in JP Application No. 2012-529808.
Office Action dated Dec. 4, 2017 in CN Application No. 201410178374.2.
Office Action dated Dec. 9, 2016 in U.S. Appl. No. 14/593,051, by Gross.
Office Action dated Feb. 16, 2017 in CN Application No. 2014101783189.
Office Action dated Feb. 21, 2012 in U.S. Appl. No. 12/689,249.
Office Action dated Feb. 24, 2015 in U.S. Appl. No. 14/258,661 by Cabiri.
Office Action dated Feb. 24, 2017 in U.S. Appl. No. 13/964,651, by Gross.
Office Action dated Feb. 28, 2014 in CN Application No. 201180006571.0.
Office Action dated Feb. 4, 2014 in EP Application No. 11 707 942.6.
Office Action dated Jan. 10, 2017 in U.S. Appl. No. 14/193,692, by Gross.
Office Action dated Jan. 30, 2013 in CN Application No. 200880117084.X.
Office Action dated Jan. 8, 2013 in JP Application No. 2010-527595.
Office Action dated Jan. 8, 2014 in U.S. Appl. No. 13/521,167 by Cabiri.
Office Action dated Jul. 13, 2011 in U.S. Appl. No. 12/559,563 by Cabiri.
Office Action dated Jul. 2, 2012 in U.S. Appl. No. 13/272,555 by Cabiri.
Office Action dated Jul. 28, 2020 in Japanese Application No. 2018-538074.
Office Action dated Jul. 3, 2017 in CN Application No. 2014101783742.
Office Action dated Jul. 31, 2015 in U.S. Appl. No. 13/521,181 by Cabiri.
Office Action dated Jul. 7, 2014 in U.S. Appl. No. 12/244,666 by Gross.
Office Action dated Jun. 10, 2016 in U.S. Appl. No. 13/964,651 by Gross.
Office Action dated Jun. 14, 2018 in U.S. Appl. No. 13/874,121, by Degtiar.
Office Action dated Jun. 2, 2016 in CN Application No. 2014101783189.
Office Action dated Jun. 3, 2014 in JP Application No. 2010-527595.
Office Action dated Jun. 4, 2015 in U.S. Appl. No. 13/667,739 by Cabiri.
Office Action dated Jun. 9, 2017 in EP Application No. 14166591.9.
Office Action dated Jun. 9,2 017 in EP Application No. 14166596.8.
Office Action dated Oct. 6, 2020 in Japanese Application No. 2018-538527.
Partial European Search Report dated Nov. 24, 2015 in EP Application No. 14166592.7.
Search Report dated Oct. 14, 2016 in CN Application No. 2014101783742.
U.S. Appl. No. 12/559,563, filed Sep. 15, 2009.
U.S. Appl. No. 12/689,249, filed Jan. 19, 2010.
U.S. Appl. No. 12/689,250, filed Jan. 19, 2010.
U.S. Appl. No. 13/429,840 by Cabiri, filed Mar. 26, 2012.
U.S. Appl. No. 13/472,112 by Cabiri, filed May 15, 2012.
U.S. Appl. No. 13/521,167 by Cabiri, filed Jul. 9, 2012.
U.S. Appl. No. 13/521,181 by Cabiri, filed Jul. 9, 2012.
U.S. Appl. No. 13/643,470 by Alon, filed Oct. 25, 2012.
U.S. Appl. No. 13/733,516 by Cabiri, filed Jan. 3, 2013.
U.S. Appl. No. 13/873,335 by Filman, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,017 by Cabiri, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,085 by Cabiri, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,121 by Degtiar, filed Apr. 30, 2013.
U.S. Appl. No. 13/892,905 by Cabiri, filed May 13, 2013.
U.S. Appl. No. 13/964,651 by Gross, filed Aug. 12, 2013.
U.S. Appl. No. 14/193,692 by Gross, filed Feb. 28, 2014.
U.S. Appl. No. 14/258,661 by Cabiri, filed Apr. 22, 2014.
U.S. Appl. No. 14/553,399 by Cabiri, filed Nov. 25, 2014.
U.S. Appl. No. 14/593,051 by Gross, filed Jan. 9, 2015.
U.S. Appl. No. 14/638,525 by Filman, filed Mar. 4, 2015.
U.S. Appl. No. 14/683,193 by Cabiri, filed Apr. 10, 2015.
U.S. Appl. No. 14/715,791 by Cabiri, filed May 19, 2015.
U.S. Appl. No. 14/725,009 by Bar-El, filed May 29, 2015.
U.S. Appl. No. 14/850,450 by Gross, filed Sep. 10, 2015.
U.S. Appl. No. 14/861,478 by Cabiri, filed Sep. 22, 2015.
U.S. Appl. No. 14/880,673 by Cabiri, filed Oct. 12, 2015.
U.S. Appl. No. 29/479,307 by Norton, filed Jan. 14, 2014.
U.S. Appl. No. 60/997,459, filed Oct. 2, 2007.
West Introduces the Daikyo Crystal Zenith RU Prefillable Syringe, Pharmaceutical Online, Jun. 2008, downloaded from webpage: http://www.pharmaceuticalonline.com/article.mvc/west-introduces-prefillab- le-syringe-system, Download date: Jan. 2009, original posting date: Jun. 2008, 2 pages.
Communication Pursuant to Rules 161 and 162 dated Apr. 6, 2018 in EP Application No. 16784688.0.
Copaxone(Registered), Innovative Drugs, Teva Pharmaceuticals, downloaded from webpage: http://levapharm.com/copaxone/, Download date: Jan. 2009, original posting date: unknown, 3 pages.
Daikyo Crystal Zenith(Registered) polymer, Manufactured by Daikyo Seiko, Lid. (Jun. 25, 2008).
Definition of Monolithic. In Merriam-Webster's online dictionary. Retrieved from https://www.merriam-webster.com/dictionary/monolithic (Year: 2021).
English translation of an Office Action dated Jan. 30, 2013 in CN Application No. 200880117084.X.
English translation of an Office Action dated Mar. 5, 2014 in CN Application No. 200880117084.X.
European Search Report (Partial) dated Mar. 8, 2017 in EP Application 16193157.1.
Extended European Search Report dated Aug. 7, 2014 in EP Application No. 1417477.4.
Extended European Search Report dated Feb. 12, 2018 in EP Application No. 17191756.0.
Extended European Search Report dated Feb. 13, 2017 in EP Application No. 16171626.1.
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166591.9.
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166596.8.
Extended European Search Report dated Jul. 3, 2017 in EP Application No. 16190054.3.
Extended European Search Report dated Mar. 27, 2014 in EP Application No. 14154717.4.
Extended European Search Report dated Mar. 8, 2016 in EP Application No. 14166592.7.
Extended European Search Report dated Nov. 10, 2016 in EP Application No. 08808111.2.
Extended European Search Report dated Jul. 28, 2020 in European Application No. 20172466.3.
Extended Search Report dated Aug. 7, 2014 in EP Application No. 14171477.4.
Extended Search Report dated Jul. 7, 2017 in EP Application No. 16193157.1.
Int'l Search Report and Written Opinion dated Jan. 12, 2011 in Int'l Application No. PCT/US2010/048556; Written Opinion.
Int'l Search Report and Written Opinion dated Jan. 26, 2017 in Int'l Application No. PCT/US2016/056213.
Int'l Search Report and Written Opinion dated Mar. 27, 2017 in Int'l Application No. PCT/US2016/056247.
Int'l Search Report and Written Opinion dated Apr. 21, 2017 in Int'l Application No. PCT/US2016/068367.
Int'l Search Report and Written Opinion dated Jul. 6, 2017 in Int'l Application No. PCT/US2017/022966.
Int'l Search Report and Written Opinion dated Nov. 28, 2016 in Int'l Application No. PCT/US2016/056218.
Int'l Search Report and Written Opinion dated Dec. 2, 2016 in Int'l Application No. PCT/US2016/056210.
Int'l Search Report and Written Opinion dated Dec. 5, 2016 in Int'l Application No. PCT/US2016/056233.
Int'l Search Report and Written Opinion dated Dec. 8, 2016 in Inl'l Application No. PCT/US2016/056227.
Int'l Search Report and Written Opinion dated Dec. 15, 2016 in Inl'l Application No. PCT/US2016/056258.
Int'l Search Repport (Partial), dated Dec. 20, 2016 in Int'l Application No. PCT/US2016/056247.
Int'l Preliminary Report on Patentability dated Jan. 8, 2018 in Int'l Application No. POT/US2016/056218.
Int'l Preliminary Report on Patentability dated Apr. 7, 2010 in Int'l Application No. PCT/IL2008/001312.
Int'l Preliminary Report on Patentability dated Aug. 2, 2012 in Int'l Application No. PCT/US2011/021604.
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US11/21605.
Int'l Preliminary Report on Patentability dated Jan. 18, 2018 in Int'l Application No. PCT/US2016/056210.
Int'l Preliminary Report on Patentability dated Jan. 18, 2018 in Int'l Application No. PCT/US2016/056213.
Int'l Preliminary Report on Patentability dated Jan. 18, 2018 in Int'l Application No. PCT/US2016/056223.
Int'l Preliminary Report on Patentability dated Jan. 18, 2018 in Int'l Application No. PCT/US2016/056227.
Int'l Preliminary Report on Patentability dated Jul. 16, 2015 in Int'l Application No. PCT/US2013/078040.
Int'l Preliminary Report on Patentability dated May 14, 2015 in Int'l Application No. PCT/US2013/065211.
Int'l Preliminary Report on Patentability dated Nov. 27, 2014 in Int'l Application No. PCT/US2013/039465.
Int'l Preliminary Report on Patentability dated Nov. 30, 2017 in Int'l Application No. PCT/US2016/068367.
Int'l Preliminary Report on Patentability dated Nov. 9, 2018 in Int'l Application No. PCT/US2016/056238.
Int'l Preliminary Report on Patentability dated Oct. 9, 2014 in Int'l Application No. PCT/US2013/033118.
Int'l Preliminary Report on Patentability dated Sep. 1, 2011 in Int'l Application No. PCT/US2010/048556.
Int'l Search Report and Written Opinion dated Apr. 3, 2014 in Int'l Application No. PCT/US2013/078040.
Int'l Search Report and Written Opinion dated Aug. 5, 2013 in Int'l Application No. PCT/US2013/033118.
Int'l Search Report and Written Opinion dated Jan. 7, 2014 in Int'l Application No. PCT/US2013/065211.
Int'l Search Report and Written Opinion dated Jul. 12, 2017 in Int'l Application No. PCT/US2016/056238.
Int'l Search Report and Written Opinion dated Jul. 26, 2013 in Int'l Application No. PCT/US2012/039465.
Related Publications (1)
Number Date Country
20200009316 A1 Jan 2020 US
Provisional Applications (1)
Number Date Country
62281536 Jan 2016 US
Divisions (1)
Number Date Country
Parent 16071574 US
Child 16572024 US